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By Yan Li
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In multicellular organism, bioenergetic metabolism is strictly regulated toward
efficient generation of ATP. However, in certain situations, such as in limiting oxygen or
in the rapidly proliferating system like growing juvenile or cancer cells, organisms apply
the metabolic strategy that favors the production of biomass (e.g., nucleotides, amino
acids, and lipids) over efficiency of ATP generation. The conserved estrogen-related
receptors (ERRs) are master regulators in controlling metabolic homeostasis, and good
candidates for mediating the metabolic transition induced by hypoxia and development.
xviii

xix

First, we investigate how dERR influences hypoxic adaptation in Drosophila
melanogaster. We find that dERR is required for a competent hypoxic response alone, or
together with hypoxia inducible factor (HIF), which is the main transcription factor
modulating the hypoxic adaptation. We show that dERR binds to dHIFα and participates
in the HIF-dependent transcriptional program in hypoxia. In addition, dERR acts in the
absence of dHIFα in hypoxia and a significant portion of HIF-independent transcriptional
responses can be attributed to dERR actions, including up-regulation of glycolytic
transcripts. These results indicate that competent hypoxic responses arise from complex
interactions between HIF-dependent and -independent mechanisms, and that dERR plays
a central role in both of these programs.
Secondly, we examine how dERR modulates metabolic transition toward the fatty
acid oxidation at late L3 larva stage. We show that dERR is essential for the expression
of an uncharacterized long-chain-fatty-acid acyl-CoA synthetase, CG4500, which is
subject to induction by starvation. Furthermore, late L3 larvae of dERR mutants exhibit
altered lipid profiles with elevated medium-chain and long-chain fatty acids. Together,
with the previous finding that ERR directs an early switch toward glycolysis in the
embryo, our studies indicate that ERR is a master regulator of programmed metabolic
shifts through Drosophila development.

CHAPTER 1 Introduction

1.1 Molecular mechanism of nuclear receptor function
Nuclear receptors (NRs) are a superfamily of ligand-inducible transcription factors
that control diverse processes, including metabolic homeostasis, detoxification, cellular
differentiation and embryonic development. NRs are responsible for sensing small
molecules that include steroid and thyroid hormones, vitamins, and many metabolites.
Unlike convoluted signal-transduction pathways with membrane-bound receptors, like
other transcription factors NRs directly bind to DNA and regulate the expression of
adjacent genes. Upon stimulation, these receptors, form monomers, homodimers, or
heterodimers, and transcriptionally regulate the expression of their target genes, thereby
directly controlling biological processes (1-4). There are 48 NRs in human (5), and they
can be categorized into three classes, based on their ligand-binding and DNA-binding
characteristics (2). The first class is the classical steroid hormone receptors, like
glucocorticoid receptors (GRs), androgen receptors (ARs) and estrogen receptors (ERs).
The only sources of ligands for this class of receptors are steroid hormones that are
regulated by negative-feedback control of the hypothalamic-pituitary axis. The binding
affinity between ligand and these receptors is fairly high (dissociation constant Kd = 0.01
to 10 nM) (6). Steroid receptors that are produced in their inactive form reside in the
1
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cytoplasm and/or nucleus and form complex with heat-shock proteins (HSP). Upon
binding to hormones, these receptors are dissociated from chaperone protein complexes
and are allowed to bind to specific DNA sequence known as hormone response elements
(HREs) in target genes, which consist of two inverted repeat half-sites separated by a
variable length of DNA (3). The second class of NRs is known as orphan nuclear
receptors. They do not have known endogenous ligands and in some cases even function
in a ligand-independent manner. A large subset of this category of NRs primarily binds to
DNA as monomers, but other members of this group could function as homodimers or
heterodimers. Whether or not they form dimers, only a single receptor DNA binding
domain attaches to a single half-site response element (2). The next class of NRs are the
so-called ‘adopted’ orphan receptors (also known as type II receptors), including fatty
acid receptors (PPARs), oxysterol receptors (LXRs), and the bile acid receptor (FXR).
They were first considered as orphan receptors, but naturally occurring ligands were
identified subsequently. These receptors form heterodimers with the retinoid X receptor
(RXR), and recognize hormone response elements that consist of two direct hexameric
repeats separated by varied number of nucleotides for different receptors. For example,
PPAR/RXR response element has an interspacing of one basepair (DR1), but LXREs and
FXREs have an interspacing of four nucleotides (DR4) (7, 8). They function as lipid
sensors by transcriptionally regulating genes that are widely involved in lipid
metabolism, storage, transport, and elimination. Ligand binding to these receptors causes
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dissociation of co-repressor proteins and recruitment of co-activator proteins, which
initiates a feedforward metabolic cascade that maintains lipid homeostasis (4). In addition
to the adopted orphan receptors, four NRs also form a complex with RXR, but cannot be
fit in to either feedforward or feedback models precisely. They are thyroid hormone (TR),
retinoic acid (RAR), vitamin D (VDR), and ecdysone (EcR) receptors as a Drosophila
NR. Their ligands and target pathways engage elements of both the endocrine and lipidsensing receptor pathways. For example, EcR not only acts as endocrine receptors in
regulating development and reproduction in Drosophila, but also functions as a lipid
sensor, because its ligand, ecdysone, is converted from cholesterol that is essential dietary
lipids. These four receptors may fill the evolutionary gap between steroid receptors and
adopted orphan receptors (4).
NRs consist of typical structural elements, including a variable amino N-terminal
activation domain, a highly conserved DNA-binding domain (DBD) and a relatively
conserved C-terminal ligand-binding domain (LBD). N-terminal domain containing at
least one activation function region (AF-1) and several autonomous transactivation
domains (Ad) is highly variable in length and function (9). DBD often consist of two
zinc-fingers. The first zinc-finger has a stretch of five amino acids called the P-box,
which mediates the binding between DNA and DBD (10). The second zinc-finger
contains a moderately weak dimerization interface that permits DBDs to form dimers
when exposed to a target DNA molecule (11). The relatively conserved LBD is the
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largest domain in NR protein. The 12 α-helix secondary structure of LBD is better
conserved than the primary sequence (12). As its name suggests, LBD bears the function
of interacting with ligands. But other than ligand binding, the LBD participates in several
other NR functions, such as forming homo- and/or heterodimers, nuclear localization,
formation of heat-shock protein complexes (steroid receptors only), and, most
importantly, transcriptional activation or repression (3). LBDs mediate transcriptional upregulation or down-regulation through interacting with either co-activator or co-repressor
proteins, respectively. Generally, binding to ligands causes the conformational changes in
an α-helical region in the C terminus of LBD, also known as activation function2 (AF2).
These structural changes facilitate the binding with co-repressor or co-activator proteins
that often contain a consensus sequence LXXLL in their interaction motif (12, 13).

1.2 Drosophila melanogaster as a model for nuclear receptor biology
Drosophila melanogaster, also known as the fruit fly, is a widely used model
organism. It features easy to care for, low cost, fast development, and well-established
genetic and genomic tools. It is a species in the family of Drosophilidae. The
developmental period for fruit fly varies with temperature. At 25°C, eggs normally take
24 hours to hatch as first-instar larvae (L1). L1 and second-instar larvae (L2) generally
grow 24h until molting to the next stage, and third-instar larvae (L3) normally grow 48h
until pupariation. Metamorphosis is about 5 days long, after which the adults emerge. L2
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larvae need to reach a critical mass of about 0.3mg to pupariate. Until mid-L3, larvae are
burrowed in food and eat constantly. After mid-L3, larvae exit the food and start to
wander. The larvae reach their highest wet weight and dry weight in mid-L3. In the four
days of development from embryos to mid-L3, the fruit fly larvae experience a 200-fold
increase in mass (14).
Although studies in mammals have revealed the molecular mechanism of how NRs
transcriptionally regulate target genes, their biological roles in many processes, including
development and energy homeostasis, still require further investigation. In addition to a
well-established model organism, the fruit fly has other special advantages to study NRs
biology. Firstly, the hormone signaling pathways in Drosophila is less complex
compared to humans. Only two physiologically active lipophilic hormones, the steroid
hormone 20-hydroxyecdysone (20E) and the sesquiterpinoid juvenile hormone (JH), have
been identified in fruit fly. Furthermore there are only 18 nuclear-receptor genes found in
Drosophila genome, versus 48 genes in humans. Secondly, NRs in fruit flies still
represent all the main NR superfamilies (1). Furthermore the structure and operating
function of NRs are also conserved between fly and humans. For example, ultraspiracle
(USP), an ortholog of the vertebrate RXR, works as an heterodimeric partner for many
fly NRs, just as its vertebrate counterparts (15). Hepatocyte nuclear receptor 4 (HNF4) is
a good example of the functional similarity of NRs between flies and humans. HNF4 has
two paralogs in mammals, HNF4α and HNF4γ. In humans, it has been shown that
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HNF4α is associated with MODY (early onset type 2 diabetes), whose patients show
defects in the expression of genes involved glucose and lipid metabolism genes. But the
function of HNF4γ is not very well understood (16, 17). Genetic mutation of HNF4 in
flies revealed reduced ability to generate energy from stored fat under starvation through
significant down-regulation of genes involved in lipolysis and β-oxidation. Together with
the fact that long chain fatty acid (LCFAs) can tightly bind with and activate HNF4, it
suggests that HNF4 is activated by fatty acids released from triglycerides, and then
induces genes involved in fatty acid oxidation for energy production. This is a feedforward model; similar to the model of adapted orphan receptors introduced previously
(18). Lastly, I want to point out that our work on the estrogen-related receptor (ERR),
which is the main focus of this document, is another great example of using fruit fly as an
ideal system for investigating the regulation and function of NRs in vivo.

1.3 Estrogen-related receptors (ERRs) control metabolic gene networks in mammals
Estrogen-related receptors (ERRs) were the first orphan nuclear receptors found in
the NR superfamily. There are three paralogs (ERRα, β, and γ) in mammals. ERRα
(NR3B1) and ERRβ (NR3B2) were first discovered in a screen to identify genes
encoding proteins closely related to estrogen receptor α (ERα, NR3A1) from kidney and
heart (19). ERRγ (NR3C3) was found later by several studies (20-22). In addition to the
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three isoforms, several splice variants of ERRβ and ERRγ were also identified in humans,
but their function is not currently understood (23).
Each of these ERRs has the typical structural elements of NRs, including a nonconserved NTD, a highly conserved DBD, and a fairly conserved LBD. Unlike the other
NRs, the three ERRs share appreciable amino acid similarity in their NTDs.
Posttranslational modification, including mainly phosphorylation and sumoylation, can
affect the transcriptional activities of ERRs. Phosphorylation on serine 19 subsequently
results in sumoylation of lysine 14 in ERRα and γ, leading to inhibition of the
transcriptional activity of both receptors via a functional phospho-sumoyl switch motif
(24, 25). Interestingly, PPARγ also has a phospho-sumoyl switch motif within its NTD
(26), which suggests that phosphorylation-dependent sumoylation might play an
important role in the transcriptional control of energy metabolism by nuclear receptors.
ERRs recognize the ERR response element (ERRE) containing the consensus sequence
TCAAGGTCA, as monomer, a homodimer, or heterodimer (27). In addition to
recognizing an ERRE, that is a single core motif preceded by three nucleotides, ERRs can
also interact in tubes with estrogen response element (ERE) that is an inverted repeat of
AGGTCA with three nucleotides in between (28). However, investigations have revealed
that ERRs tend to regulate their target genes, and also ER targets via ERREs, rather than
an ERE. Studies done in breast cancer showed that ERRα is preferentially recruited to
ERRE enriched regions, and binding to EREs happen infrequently and mostly when
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combined with an ERRE (29). It suggests that ERRα regulates transcription in an ERαindependent manner in breast cancer cells. So the overlapping function between ER and
ERRs is not as important as it was anticipated. Although ERRs are orphan NRs, their
LBD has a conserved AF-2 helix motif and can interact with synthetic molecules like 4hydroxytamoxifen, co-activator such as PPARγ coactivator-1α and β (PGC-1α/β), and corepressor proteins such as RIP140 (30, 31). Notably, the AF-2 motif stays in an active
configuration even in the absence of a ligand, which suggests that ERRs are capable of
binding to co-activators no matter the presence of ligands (32). In fact, full transcriptional
activity of ERRs depend on PGC-1α/β in most cellular contexts, which makes PGC1s
function as alternate protein ligands for the ERRs (33).
The expression pattern for ERR isoforms is not uniform. However, all three of them
are abundantly present in organs maintaining high metabolic needs, including the heart
and kidneys. ERRα is expressed in most tissues and in more abundant quantities than the
other two isoforms. Other than heart and kidney, ERRα is also highly expressed in the
intestinal tract, skeletal muscles, and brown adipose tissue (BAT), but ERRβ and ERRγ
tend to be expressed in organs associated with basal metabolic functions. This
distribution hints that three ERR isoforms collectively play key roles in regulating
networks of energy metabolism (34).
The ERRs are recruited to the promoter regions of nearly all enzymes involved in
each step of the tricarboxylic acid (TCA) cycle, all parts of the oxidative phosphorylation
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(OXPHOS) apparatus, lipid, glutamine, amino acid, nucleic acid and pyruvate
metabolism and energy sensing in metabolic tissues (35-41). ERRs also bind to the
regulatory region of more than 700 nuclear genes encoding mitochondrial proteins in
many tissues and function collectively with PGC1 α and β to regulate mitochondrial
biogenesis (42). Although all ERR isoforms are involved in controlling metabolic
homeostasis, the specific function for each isoform is distinct and sometime even
conflicting. ERRα, together with PGC-1α, transcriptionally regulates medium-chain acylcoenzyme a dehydrogenase (MCAD), which is the rate-limiting enzyme of tissue FAO.
Other studies have found a more profound role for ERRα in metabolic regulation. In
SAOS2 cells, the ERRα/PGC-1α complex up-regulates 151 nuclear genes that encode
proteins involved in many aspects of mitochondrial functions (mitochondrial protein
synthesis and transport across the mitochondrial membrane, FAO, the TCA cycle, and
OXPHOS) (43). However, ERRα null mice are lean and resistant to diet-induced obesity,
display substantial impaired lipid absorption in the intestine and are incapable of adapting
to cold temperatures (44-46). These phenotypes are unexpected considering that ERRα
up-regulates genes involved in FAO and mitochondrial energy expenditure. It has been
hypothesized that ERRα might be important in fat absorption in intestine, but this idea
needs further investigation. Furthermore, ERRα is responsible to adjust energy imbalance
induced by physiological pressures. For example, ERRα is essential for inducing
mitochondrial reactive oxygen species (ROS) production in response to IFN-γ in bone
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marrow-derived macrophages, as well as the adaptive bioenergetic response to
hemodynamic stressors in heart (41, 47). These phenomena propose that ERRα could be
a crosslink between metabolism and inflammation. Unlike ERRα null mice, mice lacking
ERRγ present a lethal phenotype shortly after birth, due to their failure to switch from
primarily depending on glycolysis to oxidative metabolism as a newborn pup. ERRγ also
plays a role in promoting myogenesis. Overexpressing either constitutively active ERRγ
or wild-type ERRγ in skeletal muscle enhances mitochondrial enzyme activity, exercise
capacity, and expression of genes involved in fat metabolism. And overexpressing ERRγ
promotes a switch toward more oxidative fiber types and vascularization in muscle (48,
49). In contrast, muscle specific loss of function of ERRγ form immature myotubes with
reduced mitochondrial content and altered distribution, increased rates of medium-chain
FAO, decreased rates of glucose oxidation and oxidative stress (50). These phenotypes
suggest that the ERRγ, but not ERRα, is crucial for establishing and keeping a basal
oxidative metabolic gene program (40). The function of ERRβ is not studied as
extensively as the other two isoforms. This is probably because ERRβ null mice are
embryonic lethal due to abnormal differentiation of the trophoblast lineage (51).
However, the phenotypes of ERRβ null and ERRγ null mice also support the idea that the
ERRs also control cell growth and differentiation during development.

1.4 ERRs is a potential therapeutic target in human diseases
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ERRs are excellent drug target candidates, because the tertiary structure of their
ligand-binding domains often permit binding of full and partial agonists, antagonists and
inverse agonists (52). Emerging studies show that pharmacologically targeting ERRs
could have a beneficial impact on human diseases, including breast cancer and metabolic
disorders (obesity and type 2 diabetes).
As discussed previously, ERRα null mice are lean and resistant to high fat induced
obesity (44). But the underlying molecular mechanism for this phenotype is not
understood. It is not clear whether using a potent ERRα antagonist will lead to a similar
phenotype. One epidemiological study in 703 Japanese individuals observed that a higher
ERRE copy number was associated with a higher body mass index (53).This result would
agree with the lean phenotype observed in the ERRα-null mice because more ERRα
expression would lead to a higher body weight. However, a genome wide association
study (GWAS) done in 334500 Danish white individuals revealed that ERRα is not
associated with obesity, type 2 diabetes, or related quantitative traits (54). However,
recent studies found that fasting and diabetes conditions induce hepatic ERRγ expression,
which leads to increased expression of gluconeogenic genes and blood glucose in wild
type mice. Also, ablation of hepatic ERRγ gene expression decreases gluconeogenic
genes expression and normalizes blood glucose levels in mouse models of T2DM (55,
56). Interestingly, another epidemiological study found that the levels of bisphenol A,
which has been shown to bind ERRγ with high affinity, in humans are linked with type 2
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diabetes and metabolic dysfunction (57). However, further investigations still need to be
done to address the specific molecular mechanisms that individual ERR isoforms affect
the pathology of metabolic disorders including obesity and type 2 diabetes.
ERRs have also been found to be associated with cancer progression. ERRα has been
found to be correlated with recurrence and adverse clinical outcomes; however, ERRγ is
associated with favorable prognosis. In ovarian cancer cells, ERRα is expressed at high
levels and correlates with advanced tumor stages and grades (58). In colorectal cancers,
another study found that the mRNA level for ERRα is higher in the cancer mucosa than
in the surrounding normal mucosa (59). In a breast cancer model, ERRα is not only
inversely associated with ERα and the progesterone receptor (PR), which are markers of
good prognosis and hormone sensitivity, but also found to be positively correlated with
ERBB2 (a marker of aggressive tumor), Myc oncogene, the proliferation marker Ki-67
and the NR co-activator AIB1 (60-63). In contrast, ERRγ is positively linked with ER
and ERBB2 that are marks of favorable prognosis in breast cancer (60). ERRα also has
been shown to regulate the proliferation and migration of cancer cells. In a mammary
gland xenografts model, ERRα can promote proliferation through inducing the expression
of vascular endothelial growth factor (VEGF) and osteoprotegerin (OPG) (64). VEGF
and OPG can function together to stimulate angiogenesis. Also, another study showed
that down-regulation of ERRα would result in decreased proliferation and migratory
capacity through down-regulating the expression of WNT11 and CCNE1 (65).
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Importantly, because ERRs stand at the center hinge of the metabolic network, it would
be surprising if ERRs did not regulate the distinct metabolic profile in cancer pathology.
To support the fast growing profile, cancer cells undergo metabolic reprogramming that
features a metabolic shift from oxidative respiration to an aerobic glycolytic profile. This
phenomenon is called the Warburg effect (66, 67). The regulatory role of ERRs on
metabolic transitions in fast growing system will be discussed extensively in the
following manuscript. Lastly, I want to point out that ERRs can interact with functional
HIF-1 and stimulate HIF-induced transcription, which also contributes to cancer
pathology from not only metabolic perspectives (68). However, only a few HIF-1α target
genes were tested in vitro in this study. The physiological role that the ERR/HIF complex
plays under hypoxic conditions has not been tested. The regulatory role of dERR under
hypoxia will be extensively discussed in chapter 2.

1.5 ERR regulates the metabolic transitions in fast growing programs (Warburg effect in
cancer and Drosophila development)
In the first four days of development from embryos to mid-L3, Drosophila larvae
experience a dramatic increase in mass as discussed in section 1.2. The fast-growing
programs of larvae and cancer cells have similar metabolic needs. A large number of
nucleotides, amino acids and lipids are needed to either grow (larvae) or proliferate
(cancer). When larvae need to grow rapidly, they primarily depend on aerobic glycolysis
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instead of OXPHOS, a program that resembles the Warburg effect during development.
Again as mentioned previously, the Warburg effect refers to the phenomenon that most
proliferating cell, including cancer cells but not limited to them, primarily rely on
glycolysis rather than mitochondrial OXPHOS even under aerobic conditions (69, 70).
However, normal differentiated cells depend primarily on mitochondrial OXPHOS to
generate the energy needed for their function and growth. OXPHOS is aerobic, i.e. it uses
oxygen. Later research found that the lower the OXPHOS capacity of tumor cells, the
more aggressive they are (71). OXPHOS generates ATP more efficiently than does
glycolysis. Catabolizing one mole of glucose by TCA cycle and OXPHOS can produce
approximately 36 moles of ATP. But catabolizing one mole of glucose by aerobic
glycolysis can only generate 2 moles of ATP. This raises the question why fastproliferating tumor cells prefer glycolysis as their major way to produce energy.
Originally, Warburg hypothesized that cancer cells have a defect in their mitochondria
which leads to impaired aerobic respiration. However, later studies showed that many
cancer cells largely maintain their mitochondrial function (72, 73). Alternative
explanations of the Warburg effect are required to better understand this phenomenon.
One possible explanation is that ATP production is not an issue when resources are
abundant. Normal cells do not take up nutrients such as glucose unless they are
stimulated by growth factors. But cancer cells have altered receptor-initiated signaling
pathways and constitutively take up nutrients. This provides sufficient energy for the
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survival and growth of tumor cells (74, 75).

Proliferating cells have metabolic

requirements in addition to their need for ATP. They must replicate all the cellular
contents to produce daughter cells in mitosis. Thus, they need a large number of
nucleotides, amino acids and lipids to produce new cells. For most mammalian cells,
glucose and glutamine provide most of the carbon, nitrogen, free energy, and reducing
equivalents. A glucose molecule can produce 36 ATPs (full oxidation), or 30 ATPs and 2
NADPHs (which go into the pentose phosphate pathway), or 6 carbons for
macromolecular synthesis. From this perspective, ATP is not the only material needed for
growth by cancer cells, but acetyl-CoA for fatty acids, glycolytic intermediates for
nonessential amino acids, and ribose for nucleotides are all necessary as macromolecular
precursors to support the proliferation of cancer cells (76). Cancer cells therefore need to
catabolize glucose in such a way to provide all these resources, not just ATP. For
example, a study showed that glioblastoma cells in culture convert about 90% of glucose
and 60% of glutamine they take into lactate or alanine, and meanwhile NADPH is
actively generated and important for fatty acid synthesis (77). Lactate dehydrogenase
(LDH) is a key enzyme involved in converting glucose and glutamine to lactate. Possibly,
LDH activity is required for generating enough NADPH which is needed by the fast
proliferation. In many breast cancer cell lines and tissue sections, LDH activity has been
found to be increased. More interestingly, later studies showed that inhibiting LDH
activity in cancer cells stimulated their mitochondrial respiration and impaired their
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proliferation (78). Furthermore, several studies showed that mutations of metabolic
enzymes can directly assist carcinogenesis. Mutations in genes of the TCA cycle
enzymes succinate dehydrogenase and fumarate hydratase have been found in a variety of
cancers (79, 80). Mutations in cytosolic isocitrate dehydrogenase-1 and 2 (IDH 1 and 2)
have been found in several human brain tumors (81-83). It becomes crucial to understand
the molecular mechanism that directs this metabolic reprogramming not only in cancer
cells but also in proliferating cells, in order to develop new anti-cancer therapies.
Accumulating evidence suggests that ERRs control the Warburg effect in
proliferating cells such that ERRα assists in setting an aerobic glycolytic profile, but
ERRγ rather tries to maintain the oxidative metabolic program. This hypothesis
corresponds with the observations that ERRα is linked with poor prognosis but ERRγ is
associated with better prognosis. ERRα is expressed in aggressive tumors that often
display an increase in glucose uptake (84). Furthermore, ERRα not only up-regulates
enzymes that are involved in the glycolysis pathway in breast cancer cells, but is also
indispensable for the switch from oxidative to glycolytic metabolism in hepatocarcinoma
cells (37, 85). On the other hand, the expression of ERRγ is inhibited by miR-378, which
directs a metabolic reprogramming to an aerobic glycolytic phenotype in breast cancer
cells (86). In spite of the fact that ERRα and ERRγ are recruited to the same set of target
genes, can readily form heterodimers, and share a capability to regulate genes governing
both the glycolytic and the oxidative mitochondrial respiration phenotype, the opposing
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roles of the two isoforms in the establishment of a Warburg-like profile illustrate the
complexity of metabolic reprogramming by ERR proteins in cancer cells (27). So it
becomes very important to understand how ERRs control metabolic shift in a
physiological context.
Drosophila is a great tool to study ERR biology. There is only one ERR in
Drosophila, making it an excellent tool to study ERR function. ERRs are well conserved
from flies to mammals. The dERR DBD and LBD are approximately 85% and 35%
identical to mERR DBD and LBD. In 2011, Tennessen et al. showed that the expression
of active dERR protein triggers a coordinate switch from OXPHOS toward glycolysis at
late embryogenesis in flies, which is also considered as developmental Warburg effect
(87). This report demonstrates that the role of the ERRs as regulators of carbohydrate
metabolism and metabolic programs associated with proliferating cells is highly
conserved from flies to humans. As discussed in previous sections, Drosophila undergoes
massive proliferation during the first four days of development from embryos to mid-L3.
Starting around day one after L3 onset, the larvae will go out of the food and start to
wander and be prepared for pupariation. Then in the next 4 days, pupae undergo a total
reconstruction of all body parts to form adult fly. During this period, they have to depend
on burning the fat that was accumulated in their fast growing phase (the time from
embryo to mid-L3), which is also considered as developmental starvation. Eventually, an
adult fly will be emerge and run a metabolic program that very much resembles
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differenciated mammalian cells. These phenotypes suggest flies trigger two switch-like
metabolic reprogrammings. They have to turn on glycolysis in late embryogenesis to
facilitate massive fat storage and turn it off right before pupariation in order to stop
storing and start consuming fat. There is a study that showed that dERR governs the first
transition, and hopefully our work here will provide evidence the dERR controls the
second transition, but also control metabolic transitions induced by physical stress, like
hypoxia. I hope my work in this thesis will provide a molecular context to understand the
close association between mammalian ERR family members and human diseases, such as
metabolic syndromes and cancer.

CHAPTER 2 HIF-and Non-HIF-Regulated Hypoxic Responses Require the ERR in
Drosophila melanogaster

2.1 Introduction
Hypoxia is a condition in which the body or a region of the body is deprived of
adequate oxygen supply. Hypoxia plays an essential role in the pathology of many
disease, including heart disease, stroke, chronic lung disease, and especially cancers.
Although in the past oxygen sensing was thought to be limited to certain cells, it is now
been recognized that all nucleated cells in the body can respond to hypoxia (88). One
important way that cells adapt to limiting oxygen is by transitioning from oxidative
metabolism toward glycolytic lactate production for energy production. Specifically, cells
convert glucose to pyruvate by glycolytic enzymes, and subsequently pyruvate will be
derived either to acetyl coenzyme A (CoA) for oxidation in the tricarboxylic acid cycle
(TCA) in the present of oxygen or to lactate by lactate dehydrogenase (LDH) as a
glycolytic end product under hypoxia (89). Complementing this strategic change of
metabolism are complex shifts in the transcriptome, which add durability to the initial
hypoxic response. Hypoxia-inducible factor 1 (HIF-1) regulates the expression of genes
that mediate the adaptive response to hypoxia. The HIF transcriptional complex is
comprised of an oxygen-labile HIF-1α subunit and its stable partner HIF-1β. This
19
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pathway is central to the hypoxic response and is highly conserved from worms to human
(88). HIF-1 complex has been found to be important in the etiologies of many diseases,
including cancers and heart disease (90-92); these conditions have a hypoxic componentand therefore an altered metabolic component - that is critical to disease progression.
In mammals, HIF-1α belongs to the family of basic-helix-loop-helix (bHLH)/PAS
transcription factors. It forms a heterodimer with the constitutively expressed HIF-1β
(aka aryl hydrocarbon receptor nuclear translocator or ARNT). Together they bind to the
HIF response elements (HREs) in the promoter regions of their target genes to regulate
transcription. Under normoxia, HIF-1α expression is tightly regulated and quickly
degraded in the cytosol. Two prolyl residues in the oxygen-dependent degradation
domain (ODD) of HIF-1α are Fe(II)- and O2-dependently hydroxylated by prolyl
dehydroxylase (PHD) (93). Then, HIF-1α binds to the von Hippel-Lindau (VHL) protein
which can be recognized by the E3 ubiquitin ligase complex, leading to HIF-1α
degradation by the proteasome. In mammals the two prolyl sites are Pro402 and Pro564 (9496). Additionally, to fully function, HIF-1α needs to bind to the coactivator protein
p300/CBP. Under normoxia, an asparagine site (Asn803) in its C-terminal activation
domain (CAD) is hydroxylated by FIH-1, which prohibits HIF-1α from interacting with
p300. Without binding to p300, HIF-1α is not capable of completely up-regulating its
target genes (97-99).
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The number of transcripts impacted by HIF-1α is large and ontologically diverse.
Despite this, a few affected pathways generally characterize HIF-mediated adaptation
responses, including upregulation of angiogenic (100, 101), erythropoietic (102) and
glycolytic transcripts (103, 104). The total hypoxic response, however, is not entirely
dependent on the HIF pathway. For example, Shen et al. found 110 hypoxia response
genes in C. elegans, 47 of which were induced in the absence of HIF (105). Although
HIF-independent hypoxia-induced activities have also been identified in other organisms,
these pathways remain poorly understood, though even in mammalian cells, HIF-1α is
dispensable for hypoxic upregulation of a number of transcripts (106–108). These results
suggest that HIF-independent hypoxic signaling mechanisms may act in concert with, or
even supplant, the HIF response pathway in a context-dependent manner.
Drosophila melanogaster deal with no/low oxygen conditions well when compared
to mammals, and can survive anoxic challenge for hours at a time (109, 110). This
phenomenon is possibly due to the highly efficient gas exchange systems in flies. Flies
maintain the three fundamental components of the HIF pathway: 1) the HIF prolyl
hydroxylase (Fatiga); 2) dVHL; and 3) both components the HIF complex-dHIFα
(encoded by sima) and Tango (dHIFβ). As in mammals, dHIFα has an ODD domain that
is sufficient to direct oxygen-sensitive degradation when hydroxylated (111). While
previous studies have examined hypoxic responses in adult flies (112, 113), the precise
input that dHIFα has in this process has not been examined. In contrast, detailed studies
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have shown that dHIFα plays a vital role in directing hypoxia-driven terminal branching
of the tracheal system during development (114, 115). The Drosophila tracheal network
serves as the fly respiratory system, and it is noteworthy that its developmental branching
bears a striking resemblance to processes controlling mammalian angiogenesis (116). In
addition, similar hypoxia-induced metabolic transitions have been reported in flies and
mammals (117), although these remain poorly defined.
As thoroughly discussed in Chapter 1, the highly conserved dERR nuclear receptor
directs a developmentally-regulated transcriptional switch towards glycolytic metabolism
that supports developmental growth (87). This function is similar to that described for
ERRα in vertebrates, which is associated with glycolytic metabolism and breast cancer
(62, 118). Importantly, mammalian ERRs are also active participants in HIF-mediated
hypoxic responses. They are directly recruited by HIF-1α to HREs and are required for a
complete transcriptional response at specific promoters (68), suggesting that ERRs play a
critical role in hypoxic responses.
Principal component analysis (PCA) is a widely used technique to transform a
number of possibly correlated variables into a smaller number of uncorrelated variables
called principal components. In general terms, PCA uses a vector space transform to
reduce the dimensionality of large data sets. Using mathematical projection, the original
data set with many variables can often be interpreted in just a few variables (the principal
components). It is therefore often the case that an examination of the reduced dimension
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data set will allow the user to spot trends, patterns and outliers in the data (119). In this
study, we wanted to use PCA detect the general trends of the high-throughput GC-MS
analysis that carried out on four experimental conditions (w1118 N, w1118 H, sima N, sima
H). In our data, N is the number of metabolites and p is 4 (number of conditions). The
mathematical background of principal component analysis will be explained briefly here.
Let X denotes the N×p data matrix, where N is the number observations and p is the
dimension of each observation. PCA first find the average metabolites m which is a 4×1
vector across all metabolites. It is the center of the N data points. PCA then subtracts the
mean from all data points to form a centered data matrix Xc. Then PCA seeks the first
projection direction v1 onto which the variance of the projected data points has the
maximal variance. This projection direction v1 is called the first PC loading vector. The
projected values from data point’s Xc × v1 are called the first PC scores. The second PC
loading vector v2 is orthogonal to the first PC loading vector and maximizes the variance
of projected data points. Correspondingly, the projected values from data points Xc × v2
are called the second PC scores. The kth PC loading vector vk is orthogonal to the first (k1) PC loading vectors and maximized the variance of projected data points. The
associated projected values Xc × vk are called the kth PC scores. In our application, the
maximal number of PC loading vectors/PC scores is the dimension of the data points p.
With the all the PC loading vectors and PC scores, the original data point x can be
reconstructed as x = m + PC1 * v1 + PC2 * v2 + … + PCp * vp.
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In this Chapter, we wanted to investigate hypoxic responses in Drosophila and assess
the influence of dHIFα on transcriptional and metabolic adaptation. We report here that
the hypoxic transcriptional response segregates into distinct HIF-dependent and HIFindependent pathways. These pathways are differentially sensitive to hypoxic challenge
in a temporal fashion during development, but both pathways are most sensitive prior to
metamorphic onset and least active in the immediate hours following pupariation.
Contrary to expectations, we find that upregulation of glycolytic transcripts is HIFindependent. Our metabolic analysis suggests that loss of dHIFα has a profound and
wide-ranging effect on all aspects of carbohydrate catabolism when unchallenged in
normoxia. In hypoxia, however, dHIF (also called as sima) mutants remain unable to
mobilize glycogen, which is preferentially depleted under hypoxic conditions. We
additionally show that dERR is required during hypoxia, in that it controls a unique set of
hypoxia-regulated dERR-dependent transcripts that include HIF-independent glycolytic
genes. Altogether, our studies raise important questions regarding the breadth of HIF
involvement in hypoxic transitions and identify dERR as an essential factor that
complements HIF-dependent and -independent responses.

2.2 Methods
2.2.1 Fly strains and hypoxic treatments
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Flies were maintained on regular cornmeal-molasses-yeast media at 25°C. sima
mutants (sima07607) (120) were obtained from Bloomington Stock Center. w1118 animals
were treated as controls. dERR mutants (dERR1/dERR2) are described elsewhere (87).
dERR,sima double-mutants were generated by recombination of the sima07607 allele with
each of the individual dERR1 and dERR2 mutations. Embryos were collected at 25°C for
14 hrs onto egg caps (molasses-agar media in 35 mm×10 mm dishes) with yeast paste.
Mid-L2 larvae were transferred to a fresh egg cap with blue yeast paste (0.3%
bromophenol blue), and allowed to develop until achieving the partial clear-gut L3 stage
(-10 to -4 hrs RTP). Staged animals were moved to fresh agar plates and allowed to age
an additional 6 hours at 25°C (normoxic treatment); or, animals were placed in an airtight
Modular Incubator Chamber (Billups-Rothenberg, Inc., Del Mar, CA) for 6 hours at 25°C
after a gas mixture containing 4% oxygen balanced with nitrogen was flashed into the
chamber (hypoxic treatment). The sima07607 chromosome was carried over a TM3, twiGFP (green fluorescent protein) balancer chromosome. Homozygous mutant larvae were
sorted for the absence of GFP expression using a Zeiss Discovery V.8 dissecting
stereoscope with fluorescence at mid-L2. For lethal phase analysis in Figure 2.8B, 0–4 hr
post-hatch L1 larvae were sorted for fluorescence to assign genotype. Larvae were placed
in vials containing fresh yeast paste and were then exposed to 21% (normal air) or 4%
oxygen for 48 hrs and scored for lethality or completion of L1.
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2.2.2 Microarray analysis
Microarray analyses were performed on at least three biological replicates of w1118
animals, sima mutants, dERR mutants, and sima,dERR double-mutants at the partial
clear-gut L3 stage and treated for 6 hrs in normoxia or 4% O2. For each biological
replicate, at least 10 larvae were collected and washed with 1×PBS before
homogenization in TRIzol (Invitrogen, Carlsbad, CA) using a VWR disposable pellet
mixer. Total RNA was isolated using a TRIzol/RQ1 DNase hybrid extraction protocol
(Promega, Madison, WI). Template labeling was done using the GeneChip 3’ IVT
Express Kit according to the manufacturer’s specifications (Affymetrix, Santa Clara,
CA). Hybridizations to Affymetrix GeneChip Drosophila Genome 2.0 arrays were
performed using the manufacturer’s recommendations. Every chip was scanned at a high
resolution by the Affymetrix GeneChip Scanner 3000 according to the GeneChip
Expression Analysis Technical Manual procedures (Affymetrix, Santa Clara, CA). Raw
data were normalized with RMA (121) and analyzed with the significance analysis of
microarray (SAM) program (122). No changes below 1.5-fold were considered
significant. Additionally, the following false discovery rate percentages were imposed:
0.733% for w1118 normoxia vs. w1118 hypoxia; 0.414% for sima normoxia vs. sima
hypoxia; 0.721% for w1118 hypoxia vs. sima hypoxia; 7.84% dERR normoxia vs. dERR
hypoxia; 0.619% for w1118 hypoxia vs. dERR hypoxia; 0.662% dERR,sima double-mutant
normoxia vs. dERR,sima double-mutant hypoxia; 0.703% for w1118 hypoxia vs.
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dERR,sima double-mutant hypoxia. Microsoft Access was used to compare data sets.
Microarray data from this study can be accessed at the Omnibus website
(http://www.ncbi.nlm.nib.gov/geo) with the accession number GSE33100.

2.2.3 Quantitative RT-PCR
Total RNA samples were isolated as described above. RNA was reverse transcribed
with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystem, Carlsbad,
CA) using the manufacturer’s specifications. For real-time PCR, premixed primer-probe
sets were purchased from Applied Biosystems, with the exception of the primer set used
for amylase. For amylase, a standard SYBR Green (Bioline, Taunton, MA) protocol was
used with the primer sets: 5’ AACTACAACGACGCCAACGAG 3’ and 5’
TGGTCGGTGTTCAGGTTCTTG 3’. All amplifications were carried out on a CFX96
real-time PCR system (Bio-Rad, Hercules, CA). Experimental values were normalized to
values obtained for the Rp49 probe set. Data are reported as the mean ± SEM. All values
reported represent experiments performed on at least three biological replicates.

2.2.4 Metabolic analysis
Analyses were performed on partial clear-gut L3 larvae treated for 6 hours in
normoxia or 4% O2. After treatment, animals were washed twice in PBS pH 8.0 and
immediately frozen at -80°C. For glycogen measurements, 45 animals were split into
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three pools and the assay was performed essentially as described (18). Color intensity
was measured using a Bio-Tek Elx800 absorbance microplate reader at 540 nm. Glucose
and glucose+glycogen amounts were determined using a standard curve. The amount of
glycogen was determined by subtracting the glucose from the glucose+glycogen total.
Glycogen amounts were normalized to protein content in each homogenate using a
Bradford assay (Bio-Rad). For ATP measurements, larvae were homogenized in 300 µl
of 6M guanidine-HCl extraction buffer (100 mM Tris and 4 mM EDTA, pH 7.5). The
homogenate was heated at 70°C for 5 min and centrifuged in at 3000×g for 1 min. The
supernatant was diluted 1:750 in dilution buffer (25 mM Tris and 100 mM EDTA, pH
7.5) and spun at 14000×g for 3 min, after which 10 µl supernatant was transferred to a
96-well white opaque plate and mixed with 100 µl of luminescent solution (Invitrogen,
Molecular probes). Luminescence was immediately measured by a Bio-Tek Synergy 2
SL luminometer. The amount of ATP was determined using a standard curve. Amounts
were normalized to total protein. For lactate measurements, 300 first instar larva, 60 third
instar larva or 30 1-day-old males were split into three pools and measured as described
Monserrate et al. (2012) using Lactate Assay Kit (Biovision Milpitas, CA,) (123). For
metabolomics, analyses were performed by Metabolon, Inc. (Durham, NC). Replicates
were normalized by protein content (Bradford analysis). Recovery standards were added
to samples prior to extraction using a proprietary series of organic and aqueous solutions.
Extracts were divided into two fractions, one for GC and one for LC. Organic solvent
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was removed using a TurboVap (Zymark). Briefly, for LC/MS, split samples were dried
and reconstituted in acidic or basic LC-compatible solvents containing standards. Positive
and negative ion-optimized sample conditions were analyzed in separate injections. For
acidic reconstitutions a gradient of water and methanol containing 0.1% formic acid was
used, and for basic extracts a water/methanol gradient with 6.5 mM NH4HCO3. Analysis
was performed on a Thermo-Finnigan LTQ mass spectrometer with an electrospray
ionization source and linear ion-trap mass analyzer. For GC, samples were re-dried under
vacuum prior to derivatization under nitrogen using bistrimethyl-silyl-trifluoroacetamide.
The column was 5% phenyl with a temperature ramp of 40˚ to 300°C over 16 minutes.
Samples were analyzed using a Thermo-Finnigan Trace DSQ fast-scanning singlequadrapole mass spectrometer with electron impact ionization. Refer to Appendix table 2
for normalized data of each replicate and p- and q-values. Extensive quality control care
was applied to minimize variability between days. The Metabolon platform has been
described elsewhere (124, 125). Data values were imputed in the following way when
values fell below the threshold level of detection: when all six replicates were
undetectable, each was assigned the minimum detectable value of across all compounds
tested; when five or less replicates were undetectable, sample values were assigned the
minimum value obtained among those that were detected for a given compound.

2.2.5 Yeast two-hybrid screen and GST-pull down
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A yeast two-hybrid screen was conducted using the Invitrogen ProQuest Two-Hybrid
System. For this purpose, three cDNA prey libraries were simultaneously prepared using
the CloneMiner cDNA Library Construction Kit (Invitrogen). All the libraries (a, b, c)
were made from poly-A-selected RNA that was extracted from w1118 animals at -4, +0, or
+4 RTP, which was reverse transcribed and pooled in equal proportions before library
construction. Each library differs by only a single base pair in the adapter sequence to
facilitate expression of clones in all three frames. Extensive procedures, provided by the
manufacturer, were followed to capture clones into the pDONR222 vector. Clones in the
donor vector were subsequently recombined into the pDEST22 vector. Libraries were
titered (a=7.18E6 CFU, b=4.44E6 CFU, c=14.28E6 CFU) and sampled for average insert
size (a=1.64 kb, b=1.25 kb, c =1.60 kb) before transformation into ElectoMax cells
(Invitrogen). Transformed cells for each library were pooled (total of 6.4E6 CFU) and
grown for 22 hrs at 30°C for preparation of library DNA by standard techniques. 22lg of
library DNA was transformed into the yeast bait strain containing the LBD of dERR
(L193-R496) that had been recombined into the pDEST32 vector. A total of 5.28E5
clones were screened by auxotrophic selection. All positive hits were sequenced. GSTpulldown experiments and the expression of GST-fused ERR constructs in pGEX-4T1
were performed as described (126).

2.2.6 Statistical analysis
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A one-way ANOVA F-test was applied to test for the differences in glycogen levels,
followed by Tukey’s HSD method. For developmental qRT-PCR analysis, delta CT
values were used to perform statistical analysis, whereby a two-tailed unpaired student’s
t-test was applied for the differences in gene expression using a Bonferroni correction.
Following log transformation and imputation, a one-way ANOVA with contrasts was
used to identify significance for metabolites in the mass spec analysis (See Appendix
table 2). Cumulative hypergeometric probability was used to determine significance
between overlapping gene sets. For PCA analysis, the original scan data of metabolites in
each experiment condition (w1118 normoxia, w1118 hypoxia, sima normoxia, sima hypoxia,
dERR normoxia, dERR hypoxia) measured by GC/LC-MS were averaged and normalized
by protein concentration. For missing data, the global minimum of the non-missing
average was imputed. Then we take a logarithm with base 10 of the data. For sima
hypoxia and normoxia, there are 243 metabolites, so the final data matrix is 243×4. All
statistical analysis was performed using R 3.0.2.

2.3 Results
2.3.1 Robust transcriptional response to hypoxia in late third instar larvae
To better understand the contribution of dHIFα in the hypoxic adaptation response,
we wanted to determine the developmental time point when dHIFα was most active. To
start, we examined the wild-type expression of two known hypoxia-responsive transcripts
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in Drosophila, lactate dehydrogenase (LDH, known also as: ImpL3, CG10160), and the
HIF prolyl hydroxylase, fatiga (CG31543) (127, 128). We also examined the ratelimiting enzyme of glycolysis, phosphofructokinase, encoded by Pfk (CG4001) as a
potential hypoxia-responsive gene. We surveyed three times points, late embryo, midsecond instar (mid-L2) larvae, and late-L3 larvae by qRT-PCR to examine transcriptional
responses of whole animals that were allowed to develop in normoxia (21% O2) and then
challenged with a 4% O2 treatment for 6 hours – hereafter referred to as H-treatment
(Figure 2.1A). This level of oxygen, and this time course, has previously been shown to
mobilize the fly HIF pathway (129). As seen in Figure 2.1D, the late-L3 time point of
wandering larvae [-10 to -4 hours relative to the onset of pupariation (RTP)] is a period
where each of the three genes is significantly induced by H-treatment. This expression
profile is different from responses observed in embryos 18–24 hr after egg laying (AEL)
(Figure 2.1B) and mid-L2 larvae (Figure 2.1C), when LDH and Pfk were unresponsive to
treatment, indicating that hypoxic responses are developmentally tempered.

2.3.2 Identification of HIF-dependent and HIF-independent hypoxic transcripts
To establish the identity of the full complement of H-regulated transcripts, RNA
samples were prepared from N- and H-treated pools of control w1118 animals and sima
mutants at the late-L3 time. The sima mutant line (sima07607) contains a lethal P-element
insertion in the first intron in the sima locus, which eliminates detectable expression of
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the transcript, rendering the animals incapable of directing expression of an oxygensensitive murine LDH-reporter and, importantly, unable to respond competently to
hypoxic challenge (120, 130).

Figure 2.1 Temporal-dependent hypoxic responses. (A) Hypoxic treatment regimen of
w1118 animals that were allowed to develop in normoxia (N) until they reached one of
three developmental stages, at which point they were treated for 6 hours in N or hypoxia
(H) (4% O2). (B-D) qRT-PCR analysis was performed to assess the espression of fatiga,
LDH, and Pfk at 18-24 hr AEL, mid-L2, or partial clear-gut larvae in late-L3. All
experiments of H/N. Error bars are SEM. * = p-value<0.05 (statistically significant).
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As expected, H-treatment resulted in a pronounced change in the transcriptome. Using
the microarray scheme outlined in Figure 2.2, we extracted a series of significantly
altered gene sets (Appendix table 1). We were primarily concerned with identifying two
mutually exclusive H-regulated gene sets – HIF-independent (HI) and HIF-dependent
(HD). Transcripts that did not exhibit at least a 1.5-fold change in expression, and which
did not have a false discovery rate (FDR, q-value) of less than 1%, were not included in
any set. This high stringency means that we have likely excluded genuinely H-regulated
transcripts from our final sets, be they HD or HI. Despite this, we classified 254
transcripts as HI and 171 as HD. It is important to note that the HI and HD
categorizations reflect the hypoxic responsiveness of individual transcripts at the late-L3
time alone. The top 20 affected transcripts from the HIF-dependent and -independent
categories are listed in Table 2.1.
Gene ontology (GO) analysis (130) was performed on the hypoxia genes sets (Figure
2.3A and 2.3B). Notably, the HI gene set, and not the HD gene set, contain glycolytic
transcripts that are up-regulated in hypoxia, which was the single most statistically
impacted process in either the HD or the HI sets (Figure 2.3A). Instead of glycolytic
genes, significant GO categories were identified for HD genes involved in translational
control and RNA processing (Figure 2.3B). However, among the HD H-regulated
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transcripts are fatiga and dVHL. This suggests that dHIFα participates in a feedback
regulatory loop that attenuates its own activity.

Figure 2.2. Scheme to identity dHIF-independent (HI) and dHIF-dependent (HD)
hypoxia-regulated genes. The dHIF-independent set (640 genes), represents the direct
comparison of N- or H-treated samples from dHIF mutants. The Total H genes set (1127
genes) represents the direct comparison of N- or H-treated samples from w1118 animals.
The HI H genes set (red circle), represents the overlap of the Total H genes set with the
dHIF-independent set. The dHIF-dependent set2 (873 genes), represents the subtraction
of the dHIF-independent H genes set from the Total H genes set. The dHIF-dependent
set1 (801 genes), represents the direct comparison of H-treated samples from w1118
animals and dHIF mutants. The HD H genes set (green circle), represents the overlap
between the dHIF-dependent sets1 and 2. All genes in any of the sets are up- or
downregulated at least 1.5-fold and have a FDR of less than 1%. See Appendix table 1
for gene set lists.
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Table 2.1. List of 20 top transcripts whose expression changes in response to hypoxic
challenge in a dHIF-dependent or –independent fashion.
Top 20 HIF-Dependent Hypoxia Response Genes
˗˗˗
˗˗˗

W1118 hypoxia vs.
sima hypoxia
-67.60
-22.19

W1118 hypoxia vs.
sima hypoxia
4.82
2.47

dDPH1
˗˗˗
Branchless
˗˗˗
Fatiga
˗˗˗
˗˗˗
Lectin-28C
PH4alphaEB
˗˗˗
˗˗˗
Kruppel
˗˗˗
dFPP
˗˗˗//sequoia

diphthamide synthesis
carboxypeptidase
FGF receptor
spermine oxidase
HIF prolyl hydroxylase
choline dehydrogenase
˗˗˗
mannose receptor
prolyl hydroxylase
˗˗˗
˗˗˗
Transcriptional repression
˗˗˗
geranyltransferase
˗˗˗

-16.82
-11.90
-9.51
-7.93
-7.91
-6.85
-6.44
-6.01
-5.62
-5.34
-4.66
-4.47
-4.26
-4.25
-4.19

10.91
-2.93
10.87
8.56
7.70
2.51
4.28
1.80
3.08
5.69
4.23
-1.76
6.16
3.79
4.31

Ero1L
Serpin 28D

protein disulfide isomerase
serline-type endopeptidase
inhibitor
transcriptional activator

-3.79
-3.78

5.91
3.87

-3.54

2.98

E-class cytochrome P450
UDP-glucuronosyltransferase
lactate dehydrogenase
E-class cytochrome P450
acyl-CoA thioesterase
E-class cytochrome P450
response to stress
E-class cytochrome P450
5-aminolevulinate synthase
NADPH-Cyp reductase
E-class cytochrome P450
dnaJ homolog
UDP-glucuronosyltransferase
synaptic plasticity
chitin-binding
phosphoric diester hydrolase
HMG-CoA synthase
tumor suppressor
flavin-linked sulfhydryl
oxidase
glutathione S transferase

7.82
7.49
7.38
6.48
6.36
6.30
5.83
5.20
5.07
4.91
4.80
4.18
4.02
3.94
3.94
3.71
3.68
3.57
3.52

5.38
5.89
14.16
3.57
4.39
2.79
6.01
5.67
3.82
4.36
5.44
3.05
3.06
3.44
2.39
3.68
2.53
2.36
1.97

3.38

3.89

Probe Set ID

CG

Gene Title

Process/Function

1639737_at
AFFX-DmU46493-1_s_at
1625173_s_at
1626857_at
1627135_at
1637758_at
1638797_a_at
1637182_at
1624497_at
1634786_at
1628705_at
1636482_at
1639555_at
1629753_at
1632203_at
1628428_at
1635558_s_at

CG34330
˗˗˗

˗˗˗
˗˗˗

1627535_a_at
1636145_at

CG11652
CG4408
CG4608
CG7737
CG31543
CG9503
CG2676
CG7106
CG31022
CG14005
CG17724
CG3340
CG31706
CG12389
CG17724//
CG32904
CG1333
CG7219

1626844_at

CG5748

HSF1

Top 20 HIF-Independent Hypoxia Response Genes
1631533_at
1638182_at
1635227_at
1626324_at
1628758_at
1632021_at
1629061_s_at
1628052_at
1632343_at
1631637_a_at
1639495_at
1628660_at
1624156_at
1632639_at
1631611_at
1641169_s_at
1634072_s_at
1625134_at
1630885_at

CG10240
CG5999
CG10160
CG9964
CG1774
CG10245
CG32041
CG10241
CG3017
CG11567
CG4485
CG7130
CG18578
CG13941
CG33983
CG11050
CG4311
CG10873
CG12534

Cyp6a22
˗˗˗
ImpL3
Cyp309a1
dACOT
Cyp6a20
Hsp22//Hsp67Bb
Cyp6a17
Alas
Cpr
Cyp9b1
Hsp40
Ugt86Da
Arc2
obstructor-H
˗˗˗
Hmgs
p53
Alr

1628657_at

CG17534

GstE9
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Figure 2.3 HIF-dependent and HIF-independent hypoxic response genes. (A-B)
Gene ontology (GO) analysis was performed on sima -independent (HI) and sima dependent (HD) gene sets that were derived from microarray analysis of H- or N-treated
control (w1118) animals or sima (sima07607) mutants collected at the partial clear-gut lateL3 time. See Figure S1 for the analysis scheme. GO categories are listed in order of
statistical significance. The numbers of H-regulated genes affected are shown along with
the total number of genes in each category. All transcripts are up- or downregulated at
least 1.5-fold and have a false discovery rate (FDR) of <1%. (C) A heat map was created
to illustrate the similarity or dissimilarity of hypoxic responses observed in control and
sima mutant animals for major GO categories impacted by H-treatment. Red (upregulated), green (down-regulated), or white (no significant change) values represent
hypoxic responses observed in the backgrounds indicated. For this analysis, FDR
stringency was <1%, unless otherwise noted with * for a particular genotype, where a
relaxed gate was used (1-5%), also means that false discovery rate equals to 1-5%.

Ontology-focused heat maps were generated to compare hypoxic transcriptional
responsiveness. In addition to glycolytic genes, comparisons were made for other
metabolic categories where GO significance was identified, including oxidoreductase
activity, lipid metabolism, vitamin binding, and amino acid metabolism (Figure 2.3C).
With the exception of lipid metabolic genes, when hypoxic responsiveness is seen (up- or
down-regulated) in the control background, the majority of genes also respond in-kind in
the sima background, and usually with a similar fold change increase. These results
suggest that HIF-independent, H-sensitive mechanisms account for a large percentage of
the hypoxic response.
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2.3.3 Temporal-dependent hypoxic responses
The unexpected breadth of contribution of the HI pathway in the hypoxic response led
us to reconsider our initial observations made in Figure 2.1, where fatiga displayed a
similar response profile across each of the times assayed, and LDH and Pfk displayed a
hypoxic response at only the late-larval time. Indeed, fatiga is a HD gene, whereas LDH
and Pfk are HI genes (Appendix table 1). Were LDH and Pfk unresponsive at earlier
developmental times because the HI pathway was not active until just prior to
metamorphic onset? To address this question, we collected RNA from control animals
and sima mutants staged at times that spanned development. In all, twelve samples were
gathered: 4 embryonic times (0–6 hrs AEL [w1118 background only], 6–12 hrs AEL, 12–
18 hrs AEL, and 18–24 hrs AEL); 4 larval times (mid-L1, mid-L2, mid-L3, and -4 hr
RTP); 3 metamorphic times (0 hr RTP, +12 hr RTP, +72 hr RTP); and 1 adult time (1
day-old males). qRT-PCR was used to assess H responses of 13 select genes that
displayed varying levels of H-sensitive expression. Of those genes analyzed: five were
classified as HD genes – fatiga, spermine oxidase (CG7737), sequoia (CG17724),
branchless (CG4608), and Peroxiredoxin 2540-2 (Prx2540, CG11765); seven were
classified as HI genes – LDH, Pfk, NMNAT (CG13645), Alas (CG3017), Cyp9b1
(CG4485), Cyp6a17 (CG10241), and Cyp6a22 (CG10240); and one was highly affected
by H, but did not meet the stringency requirements for H set inclusion –CG31769, which
had a largely HIF-dependent expression profile in late-L3.
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Figure 2.4 Temporal expression of HIF-dependent hypoxic response genes. (A-E)
Developmental hypoxic response profiles from qRT-PCR analyses are shown for
transcripts that display HIF-dependent (A - fatiga, B - spermine oxidase, C - sequoia, D branchless) or largely HIF-dependent expression (E - CG31769). Control (w1118) animals
or sima mutants were challenged for 6-hrs with 4% O2. Animals were challenged at 0-6
hr after egg laying (AEL) (not from mutant), 6-12 hr AEL, 12-18 hr AEL, 18-24 hr AEL,
mid-L1, mid-L2, mid-L3, -10 - -4 hr relative to pupariation (RTP) L3, 0 hr RTP, +12 hr
RTP, +72 hr RTP, and 1-day old males. All values are from experiments performed in
triplicate from pools of biological replicates. Values are normalized to rp49 expression
and are reported as the relative fold-change of H/N. The dotted line represents no net
change in response, or a value of 1.0. The vertical black line in late-L3 is when
microarray analysis was performed. Error bars are the SEM.
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Figure 2.5. Temporal expression of HIF-independent hypoxic response genes. (A-H)
Developmental hypoxic response profile from qRT-PCR analyses are shown for
transcripts that display HIF-independent (A - LDH, B - phosphofuctokinase, C - NMNAT,
D - Alas, E - Cyp9b1, F - Cyp6a17, G - Cyp6a22) or largely HIF-independent expression
(H - Peroxiredoxin 2540-2 – we note that Prx2540-2 displays HD expression for probe
set 1631628_s_at in the microarray and is thus classified as such; however, a second,
non-overlapping probe set, 1633471_at, which is much more robustly induced in H
appears to be from HI action, although its variability is too great to classify in this

42

manner (Appendix table 1). Our qPCR primer set favors HI expression.) Control (w1118)
animals or sima mutants were challenged for 6-hrs with 4% O2. Developmental challenge
times are identical to those from Figure 2.4. All values are from experiments performed
in triplicate from pools of biological replicates. Values are normalized to rp49 expression
and are reported as the relative fold-change of H/N. The dotted line represents no net
change in response, or a value of 1.0. The vertical black line in late-L3 is when
microarray analysis was performed. Error bars are the SEM.

Several patterns emerged from the developmental analysis. First, hypoxic
transcriptional induction is most evident at the late-L3 time for each gene assayed.
Second, without exception, HD and HI genes display marked drops in H responsiveness
just after metamorphic onset. In most cases, H responsiveness is eliminated during the
hours surrounding head eversion, which is the initiation of the pupal phase. Among the
transcripts examined, HD genes were not induced in hypoxia in a sima background at any
developmental time, with the notable exception of a single point in mid-L3 for branchless
(Figure 2.4D). Finally, in the absence of dHIFα, HI genes tend to be hyper-responsive to
H challenge throughout development – this was true for all genes examined except LDH
(Figure 2.5A). The LDH profile was unique amongst those assayed, in that late-L3
expression was HI, while pupal expression appears to be dominated by HD expression.
The super-activation of LDH during the pupal phase in the w1118 background (vs. sima)
suggests that both the HD and HI pathways are capable of converging simultaneously at
the same locus to contribute to its overall expression. Collectively, these developmental
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expression data indicate that hypoxic responses are comprised of a patchwork of HD and
HI activities throughout life-stage progression.

2.3.4 sima mutants are metabolically disturbed in normoxia and are unable to mobilize
glycogen in hypoxia
The observation that glycolytic transcripts are effectively up-regulated in sima
mutants challenged with hypoxia raised the question of how metabolism was affected
under these conditions. As before, we concentrated on the late-L3 time because of its
particularly robust transcriptional response to H-treatment. We found that glycogen was
significantly depleted by control w1118 animals in H, in addition to a near 50% reduction
in the level of ATP (Figure 2.6A and 2.6B).
We tested for additional HIF-dependent metabolic defects in carbohydrate
catabolism using mass spectrometry tied to gas and/or liquid chromatography (GC/MS,
LC/MS). Extracts were prepared from animals subjected to N- and H-treatments and 243
metabolites in all major metabolic processes were measured. At first, we applied PCA
analysis on the 24 normalized metabolite data sets (6 replicates in each four experimental
conditions as w1118 N, w1118 H, sima N, sima H) to see whether the majority of
metabolites in the replicates clustered in each different conditions. We see indeed nicely
clustering of data in all four experimental conditions without obvious outliers (data not
shown). Next, we carried out PCA analysis on the raw data sets as described in section
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2.2.6 to detect the changing patterns in the four experimental conditions (w1118 N, w1118 H,
sima H, sima H). Unsurprisingly, we see that many metabolites do not change at all
within any conditions. However, if we exclude those unchanged metabolites and only
consider those do change statistically significantly, we observed an interesting
phenomenon that there is a genotype-dependent component that accounts for 71% of the
variance and an oxygen-dependent component that accounts for 25%. This result suggests
that the genotype has more influence on the change of metabolites than the oxygen
concentration.
Here, we measure 32 carbohydrate metabolites measured (Appendix table 2). The
metabolites correspond to four broad categories: 1) aminosugar metabolism; 2) fructose,
mannose, galactose, starch, and sucrose metabolism; 3) glycolysis, gluconeogenesis, and
pyruvate metabolism; and 4) nucleotide sugars and pentose metabolism (Figure 2.6C).
We found that the control response to hypoxia is characterized by a remarkable level of
metabolic stability for carbohydrate catabolites (third column in Figure 2.6C). Among
those compounds that do display significant H-induced depletions are oligomeric forms
of glucose (maltose, maltotriose, maltotetraose, and maltopentaose), which are catabolic
products from glycogen and starch breakdown (Figure 2.6C and 2.6E). These sugars feed
into the glycolytic cascade by replenishing glucose. They are successively depleted in H
the larger they are, and their reductions are consistent with a depletion of total glycogen
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seen in the w1118 response (Figure 2.6A), as well as the HIF-dependent up-regulation of
amylase in H in the same background (Figure 2.6D).
In contrast to the effects that H-treatment has on w1118 animals, sima mutants cannot
deplete glycogen in H (Figure 2.6A). Instead, they adopt a profile for the maltose
oligomers in normoxia that resembles the hypoxia-mobilized profile in control animals
(Figure 2.6C and 2.6E). This is likely a combination of two factors- the sima mutant’s
inability to effectively up-regulate amylase in H and its constitutively elevated expression
profile for amylase in normoxia that is greater than w1118 expression in hypoxia (Figure
2.6D, Appendix table 1).
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Figure 2.6. HIF-dependent effects on carbohydrate catabolism. (A) Unlike the w1118
response, sima mutants are not able to mobilize glycogen stores in response to 6-hr Htreatment in late-L3. (B) ATP levels are significantly depleted upon H-challenge by w1118
animals. Although sima mutants showed a similar trend, the decrease observed was not
significant. Levels of glycogen and ATP are normalized to total protein. (C) Shown is a
metabolic heat map of individual metabolites measured by GC/MS or LC/MS from lateL3 w1118 animals or sima mutants subjects to N (left two columns) or H (right two
columns). Six replicates were measured for each treatment group. Each replicate has 250
independently collected and pooled animals. Metabolite levels are expressed as log2
transformations of the average values, which are plotted relative to the normoxic level
obtained in the WT background. The data are normalized to total protein content. Red
indicates an elevated metabolite level; green indicates a decreased level, and black
no/little change. See Appendix table 2 for further information and statistics. (D) qRTPCR analysis showing amylase expression increases in hypoxia in control animals.
Although sima mutants have an elevated constitutive level of amylase expression, they do
not induce expression in hypoxia. (E) Integrated snapshots of the transcriptional and
metabolic response to hypoxia at 6-hr. Shown, are the metabolites and enzymes of stored
sugar and circulating sugar as they feed into glycolysis. When significant H-induced
changes were noted (fold-change > 1.5, FDR < 1%) for transcripts in microarray
experiments, those changes are noted in brackets next to the enzyme names. HD or HI
status, as classified in Appendix table 1 is also noted. Metabolite levels from mass spec
analysis are additionally shown as box and whisker plots. The upper and lower
boundaries of the box note the upper and lower quartile values, while the ends of the
vertical line indicate the maximum and minimum values. The average value is the noted
by the horizontal line within the box. Error bars are the SEM. * = p-value < 0.05.
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Figure 2.7. Lactate production in hypoxia is life-stage-dependent. Lactate
measurements from mid-L1 (A), late-L3 (B), and day-old males (C) from w1118 animals
and sima mutants treated for 0, 4, or 6 hrs in 4% O2. All measurements were determined
in triplicate. Values are normalized to protein content. Error bars are the SEM.
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Curiously, despite the clear transcriptional switch toward glycolytic energy
production at late-L3, lactate levels remained unchanged for either genotype in H (Figure
2.6C). This failure to generate lactate in hypoxia is a stage-specific block. We
independently performed lactate measurements by an enzymatic assay to confirm the
late-L3 findings made by GC/MS. Indeed, we find that mid-L1 larvae and young adults
from either the w1118 or sima backgrounds produce lactate in hypoxia, but not late-L3
larvae (Figure 2.7A–2.7C). Notably, early larval and young adult sima mutants exhibit an
exacerbated hyperlactatemic phenotype when subject to hypoxia (Figure 2.7A, 2.7C) –
this does not happen to late-L3 animals. Additionally, though the transcriptional H
response profile was largely normal for glycolytic genes in the sima mutant, profound
depletions were still observed for glucose-6-phosphate and fructose-6-phosphate in H
(Figure 2.6C and 2.6E). This is because the normoxic levels for these compounds, rather
than H-induced changes, dominate their metabolism. We also observed a HIF-dependent
increase for pyruvate in N and H. This is consistent with findings in HIF-1α-/- MEFs,
which maintain higher levels of ATP in hypoxia than WT MEFs do in normoxia (131).
Finally, the elevated level of Ru5P:Xu5P and ribulose, coupled with the depleted levels
of S7P, reveal that sima mutants display a clear split in the oxidative (NADPHgenerating) and non-oxidative phases of the pentose phosphate pathway in normoxia,
which is exacerbated by H-treatment.
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2.3.5 dERR binds to dHIFα
The only factor known to transcriptionally regulate glycolytic transcripts in
Drosophila is dERR (87). Our lab identified this orphan nuclear receptor as a potential
factor that may participate in hypoxic signaling when the dERR ligand-binding domain
(LBD) was used to repeatedly isolate sima clones in a large-scale yeast two-hybrid
screen. Of the 20 positive clones recovered in the screen, seven encoded different Cterminal fragments of dHIFα. These findings are consistent with a previous report that
demonstrated HIF/ERR interactions between the Drosophila proteins and their
mammalian homologs (68); however, there are two important aspects about HIF/ERR
complexes that we note differentiate the fly and mammalian complexes. First, we find
that the dERR DBD is dispensable for interaction with dHIFα, whereas the Ao report
showed that interaction occurs between the mammalian ERR DBD and the HIF-1α/β
heterodimer. Second, unlike in mammals (68), HIF-1β (tango) is not required for dERR
association with dHIFα in Drosophila – tango was not present in the screen. In this
respect, our findings are consistent with the findings made by Ao et al. Their two-hybrid
screen of Drosophila components also did not have a HIF-1β (68).
We validated our two-hybrid screen findings by performing a GST-pulldown with
GST-fused dERR LBD protein with full-length dHIFα, which confirmed a robust
interaction (Figure 2.8A). The C-terminal AF-2 helix of nuclear receptors often mediates
interaction with transcriptional coregulators through an LXXLL motif that is found on the
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Figure 2.8. dERR binds to dHIFα and is essential to hypoxia survival. (A) GSTpulldown experiment showing GST-fused dERR LBD association with full-length dHIFa,
which is diminished when the final 11 amino acids of the LBD are deleted (ΔAF-2).
Similarly, when the LXXLL motif in dHIFα is mutated, binding with the ERR LBD and
ΔAF-2 proteins is lessened, but not eliminated when compared to GST alone. (B) dERR
mutant animals are sensitive to H exposure and fail to successfully progress to the molt
when challenged with 4% O2. Shown also are the results of w1118 animals and sima
mutants. The L1 stage takes ~24 hrs to progress through in N at 25°C, but the allotted
time was extended to 48 hrs to account for developmental delays that are caused by H
treatment. For more details and additional data, see Appendix table 3.
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interacting protein (132). A single such sequence resides within dHIFα, at amino acids
1289–1293 (LKNLL). When the last two leucines of this sequence were mutated to
alanine and/or when the last 12 amino acids of the dERR LBD were deleted, spanning the
AF-2 helix (479–491), the interaction between the proteins was severely reduced, but not
eliminated (Figure 2.8A). These data indicate that the dERR AF-2 helix mediates a
docking point with the dHIFα LXXLL motif, but that at least one additional point of
contact is maintained between dERR and dHIFα.

2.3.6 dERR mutants are hypoxia-sensitive
We have recently shown that the orphan nuclear receptor dERR is essential for
triggering the pro-growth glycolytic program during Drosophila development (86).
Without the dERR-initiated metabolic switch, development cannot successfully proceed.
Many of the same metabolic genes that exhibit H-sensitive regulation are also misregulated in the dERR mutant. If dERR is important in the hypoxic response, as suggested
by its association with dHIFα, then the mutants should be sensitive to H-treatment. To
test this, we challenged dERR mutants and compared their H-sensitivity with sima
mutants and control animals. Indeed, 24–30 hr AEL L1 larvae challenged with constant
hypoxia resulted in sima mutant lethality (Figure 2.8B). The dERR mutants were also Hsensitive, but not to the same extent as sima embryos. Nevertheless, less than 25% of
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dERR mutant animals survived as compared to 97% survival for the w1118 background.
These data indicate that dERR is essential for hypoxic adaptation.

2.3.7 dERR is essential for HIF-dependent and HIF-independent responses
Using the same analytic framework that was used to assess sima involvement in the
late-L3 larval hypoxic response, we collected RNA samples from dERR mutants and
dERR,sima double-mutants for microarray analysis to determine how loss of ERR alone
or ERR and dHIFα together would affect hypoxic responses (Figure 2.9). Through these
analyses, we identified 282 dERR-dependent (ED) transcripts and 207 double-mutantdependent (DM) transcripts whose expression changed in hypoxia (Figure 2.10A,
Appendix table 1). The ED and DM H-genes sets encompass a variety of highly
significant GO categories, including H-induced kinases and transferases that specifically
require dERR, and a host of nucleolar and RNA processing transcripts that are
coordinately up-regulated in hypoxia due to the lack of both dERR and dHIFα (Table 2.2,
Appendix table 1).
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Figure 2.9. Scheme to identity ERR-dependent (ED) and ERR&HIF-dependent
(DM) hypoxia-regulated genes. The HD H-genes (green circle) were determined as
outlined in Figure 2.2. The dERR-independent set (blue outlined oval) represents the
direct comparison of N- or H-treated samples from dERR mutants. The Total H-genes set
(black outlined oval) represents the direct comparison of N- or H-treated samples
from w1118 animals. The dERR-dependent set 2, represents the subtraction of the dERRindependent set from the Total H-genes set. The dERR-dependent set1 represents the
direct comparison of H-treated samples from w1118 animals and dERR mutants. The ED
H-genes set (blue circle), represents the overlap between the dERR-dependent sets1 and
2. The ERR&HIF-dependent H-genes set (red circle) was determined using the same
scheme as above, except that the dERR,sima double-mutant was used instead of
the dERR mutant. All genes in any of the sets are up- or downregulated at least 1.5-fold
and have a FDR of less than 1%, except for the dERR-independent set (noted with *).
FDR constraints were relaxed for this set alone. It includes FDR scores that are elevated
to <7%. See Appendix table 1 for gene set lists.
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Table 2.2 List of Gene ontology (GO) analysis of ERR-dependent and ERR&HIFdependent hypoxic genes.
dERR-Dependent (ED) H genes
GO Category
Number of Genes (total)
Up-Regulated ≥ 1.5-fold --- 56 total
No Significant Category
--/-Down-Regulated ≥ 1.5-fold --- 124 total
- kinase activity
22 (371)
- transferase activity, phosphorus23 (446)
containing
- transferase activity
32 (851)
- phosphotransferase activity,
20 (333)
alcohol as acceptor
- glycolysis
5 (11)
- protein kinase activity
16 (275)
- hexose catabolic process
5 (16)
- protein serine/threonine kinase
13 (190)
activity
- glucose metabolic activity
5 (22)
- IMP biosynthesis
3 (5)
dERR & dHIF-Dependent (DM) H genes
Up-Regulated ≥ 1.5-fold --- 61 total
- nucleolus
8 (95)
-ribosome biogenesis and
5 (33)
assembly
- nuclear lumen
8 (348)
- ribonucleoprotein complex
5 (100)
biogenesis
- pseudouridine synthesis
2 (13)
- rRNA processing
3 (20)
Down-Regulated ≥ 1.5-fold --- 146 total
No Significant Category
--/--

p-value
--/-1.6 e-10
8.1 e-9
6.3 e-7
9.0 e-6
5.0 e-5
2.2 e-4
2.2 e-4
2.4 e-4
9.7 e-4
1.6 e-3

3.8 e-7
1.7 e-5
1.5 e-3
1.5 e-3
2.0 e-3
2.1 e-3
--/--

The numbers of H-regulated genes affected are shown along with the total number of genes in each
category. All transcripts are up- or downregulated at least 1.5-fold and have a false discovery rate (FDR) of
<1%.
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Venn analysis was used to assess the similarity of the independently derived H-gene
sets (HI, HD, ED, DM). The overlapping pattern of the ED genes set with the mutually
exclusive HI and HD sets demonstrates that dERR significantly affects both HIFdependent H-genes (71 transcripts) and HIF-independent genes (54 transcripts) (Figure
2.10B). Among the overlap between the HI and ED genes sets are all the glycolytic
transcripts that are upregulated in hypoxia. These data reinforce our earlier findings that
demonstrate that at metamorphic onset, dHIF is not part of the hypoxic-induced
glycolytic shift. They suggest that a portion of the HI response is attributable to dERR.
Given that dERR can interact with dHIFα, and that it can impact hypoxic
transcription independent of HIF, we anticipated that the DM H-genes set would
significantly overlap the ED and HD genes sets. Indeed, this is the case – as shown by
Venn analysis, the DM set has more overlap with the HD and ED sets than not (Figure
2.10C). A listing of the top hypoxia-sensitive transcripts in the various Venn overlapping
regions can be found in Figure 2.10D.
To verify that loss of dERR and/or dHIFα selectively eliminates/diminishes hypoxic
induction, RNA samples were independently collected from control animals, sima
mutants, dERR mutants, and double-mutants (Figure 7D). Six genes were chosen for
further analysis by qRT-PCR. Independent samples were separately collected and
prepared for RNA extraction. The results demonstrate that the factor-dependent
classification we employed for hypoxic responsiveness is accurate. For example, Pfk is
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classified as HI, ED, and DM, indicating that hypoxic regulation should be affected in the
double-mutant and the dERR mutant backgrounds, but unaffected in the sima mutant –
this is the pattern that is observed (Figure 2.10E). Similar trends also held true for fatiga
and spermine oxidase, which were expected, respectively, to only respond in the dERR
mutant background, or not in any of the three mutant lines. With the exception of a
modest H-induction in the dERR mutant for spermine oxidase the responses were as
expected. Hypoxic responses for NMNAT, LDH, and ALAS were all expected to display
the same pattern; which is that only in the dERR background will H-responsiveness be
significantly reduced/eliminated. Responses were, by-and large, as expected, except for
the significant H-induction of LDH in the in dERR mutants.
These data indicate that dERR and dHIFα have a different activity profile when in the
presence of the other, than either protein has by itself, and suggest that promoter-specific
actions of different HIF and/or ERR complexes drive a large percent of hypoxic
responses at metamorphic onset. In certain cases, loss of one factor does not influence the
other’s response, as with loss of dHIFα for the dERR-mediated Pfk response (Figure
2.10E). In other cases, loss of either dHIFα or dERR renders the H-response incomplete,
such as occurs with spermine oxidase. And, still in other cases, loss of one factor is more
detrimental for H-induction than is loss of both, as with ALAS. Responses of this type
appear to suggest that, at certain loci, dHIFα acts as a negative regulator of hypoxic
transcription in the absence of dERR but not in its presence.
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Figure 2.10. The influence of dERR and dHIFα on hypoxic transcripts. (A) HIFindependent (HI), HIF-dependent (HD), ERR-dependent (ED), and ERR&HIF-dependent
(DM) gene sets identified by microarray schemes outlined in Figures 2.2 and 2.9. Circles
are scaled to size by number of transcripts in each set. (B) A Venn diagram
demonstrating the overlap of the HI/HD/ED H-genes sets. Note, HI and HD genes sets
are, by definition, mutually exclusive. The asterisks indicate that the overlap is significant
(p-value<0.05), as determined by hypergeometric probability. (C) A Venn diagram
demonstrating the overlap of the HD/ED/DM H-genes sets. qRT-PCR analysis of
hypoxia-regulated genes falling into specific Venn overlaps, as indicated by arrows. (D)
The top ten affected transcripts, as assessed by the H-responses measured in the control
background, for each of the seven Venn categories shown in Figure 2.10C. Hypoxic
expression for each transcript in the different mutant backgrounds (compared to w1118) is
reported as fold-change difference. Additionally shown is the N/H ratio obtained for
w1118 animals. (E) Normoxic and hypoxic expression of each of the six genes (Pfk, fatiga,
spermine oxidase, NMNAT, LDH, ALAS) was determined using RNA collected from
animals of the indicated genotypes at late-L3. Samples were collected in triplicate and are
independent from those used in the microarrays. Values are normalized to rp49
expression and are reported relative to the value obtained for w1118 in normoxia.

2.4 Conclusions and Discussions
Our results underscore the complexities of adaptive responses in hypoxia, which are
life-stage specific and controlled by multiple H-sensitive pathways. Although our data
confirm that HIF is a major transcriptional driver of hypoxic responses, we also define
distinct HIF-independent responses. These data raise new questions about dHIFα
collaboration and challenge the notion that the HIF complex has little or no normoxic
role. In addition, we show that a significant fraction of HIF-independent pathways can be
attributed to the ERR nuclear receptor.
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Among the HIF-independent genes were numerous glycolytic transcripts that are
well-known responders to hypoxia (112, 117, 127). The fact that these genes are as
effectively up-regulated in sima mutants as they are in a control response was surprising,
particularly considering the known role of HIF-1α in this process (133). We find that
dERR is the overriding factor that mediates hypoxic up-regulation of glycolytic genes
(Pgi, Pfk, GAPDH2, enolase) just prior to metamorphic onset.
Our findings, however, do not exclude dHIFα contribution in hypoxic expression of
HI genes at other developmental times. The super-induction of LDH during
metamorphosis in w1118 animals versus sima mutants is consistent with this scenario
(Figure 2.5A). These temporal- and context-specific differences may explain the wide
variability in hypoxic responses that have been seen between cell-types (103, 134),
despite the ubiquitous presence of the HIF pathway. Furthermore, they may account for
discrepancies between our data collected on Drosophila and reports on mammalian
systems. For example, LDH is a HIF-independent hypoxia-regulated gene in late-L3
animals. However, loss of dERR has a greater effect on the diminution of hypoxic
induction at this developmental time than does loss of dHIFα (Figure 2.10C). But, this
effect is short-lived, because just hours later, when the larva transitions into a pupa,
dHIFα appears to work in combination with a non-HIF pathway to elicit hypoxic
responsiveness (Figure 2.5A). This combinatorial response during Drosophila
metamorphosis is consistent with vertebrate studies that show LDH expression is the
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product of HIF-1 action that also requires the presence a cAMP response element for full
hypoxic induction (133, 135). Thus, in addition to different pools of potential coregulatory molecules that may significantly alter HIF-dependent transcription, entirely
different transcriptional pathways, with their own triggers of hypoxic induction, refine
the H response. Given the right spatiotemporal setting, HIF-independent pathways may
displace (or substitute for) the HIF pathway altogether, a result that is consistent with our
data. Further support of this idea is evident in the expression of Alas2, the rate-limiting
enzyme for heme production. Alas2 has been identified as a HIF-dependent and a HIFindependent hypoxia-regulated gene in mammals (136–138). In our hands, ALAS is Hresponsive, and displays HIF-independent and ERR-dependent up-regulation, which may
be subject to dHIFα negative regulation in dERR’s absence (Figure 2.10E).
The dynamic patterns of temporal expression of HI and HD genes raise the
fundamental question of how hypoxic responses are regulated through development and
into the adult. Low-oxygen responses are not one-size-fits-all programs that mitigate
oxidative damage and metabolic imbalance; they must be coordinated with
developmental progression and metabolic state. In particular, late-L3 wandering larvae
exhibit a hypersensitive transcriptional response to hypoxia for HIF-independent/ERRdependent glycolytic genes. This includes a robust LDH induction (Figure 2.5A).
Paradoxically, however, late-L3 larvae do not produce lactate in the 6-hr hypoxic
challenge (Figure 2.6C, 2.6E, and Figure 2.7). In contrast, at other developmental times
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(L1, adult), animals correspondingly produce lactate in hypoxia, even though they remain
transcriptionally incompetent to induce LDH transcript (Figure 2.7 and Figure 2.5A). We
speculate that the atypical transcriptional and metabolic hypoxic profiles of the late-L3
larva are a product of its developmentally programmed energetic state, which at this time
is transitioning from low to high efficiency (Pfk expression dramatically decreases in late
larvae, Figure 3.3A). Just prior to the wandering L3 time, larvae are prolifically growing,
and in a state of metabolism that is fueled by aerobic glycolysis – this metabolic program
is ERR-dependent (87). Just after this developmental time, larvae initiate metamorphosis,
which will impose 5 days of developmentally forced starvation. During this lipid-driven
phase (139), metabolism is characterized by high efficiency OXPHOS.
In contrast to the switch-like hypoxic expression of HIF-independent glycolytic
transcripts, the HIF prolyl hydroxylase fatiga displays relatively uniform expression
throughout development (Figure 2.4A), suggesting that regulation of the HIF pathway, by
HIF itself, is equally important at all times for the animal. Such disparities in induction
are only understood in context. While our studies here provide a framework with which
to view H responses, they indicate that further developmental analysis is needed to more
fully appreciate hypoxic response pathways and the mechanisms that specifically support
their activities.
Although we have emphasized the transcriptional and metabolic impacts of hypoxia
on carbohydrate catabolism, the range of our data sets indicate that many important
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hypoxia-induced changes are thus far unappreciated and await further investigation. What
is the significance, for instance, of the greater than 10-fold increase of HIF-dependent
expression of dDPH-1 (CG11652) in hypoxia (Table 2.1)? DPH-1 is a tumor suppressor
that is responsible for the first step of the unique protein modification that occurs on
elongation factor 2 (eEF2), which converts a histidine residue to diphthamide. This
residue is the target of diphtheria toxin that can shut down protein synthesis through
ADP-ribosylation. Although diphthamide formation is conserved from archaea to human,
its significance on cellular function is not clear, as it is dispensable for protein elongation
(140). However, it has been implicated in translational fidelity (141) and is likely an asset
under stress (142). GO analysis performed on HD H-regulated genes indicate that dHIFa
is important in replenishing select protein translation/RNA processing transcripts. From
this perspective, DPH-1 induction by dHIFα may be indicative of a regulatory role of
hypoxic translation for HIFs. Such a role would be consistent with a recent report from
mammals that demonstrates a HIF-2α-dependent association with ribosomal/translational
control proteins and the selective hypoxic translation of transcripts containing an RNA
hypoxic response element in the 3’UTR via a mechanism involving eIF4E2 (143).
Our analysis of carbohydrate catabolism identifies amylase-mediated breakdown of
glycogen as the fuel of first resort in hypoxia (Figure 2.6). This catabolic pathway feeds
into glycolysis and supplies needed glucose for increased glycolytic flux, obviating the
need to draw on circulating sugar in the form of trehalose, which did not change in the 6-
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hr challenge. The strategy of glycogen mobilization allows animals to maintain a
remarkably stable profile for a wide variety of carbohydrate catabolites.
Trehalose levels are substantially elevated in sima mutants, regardless of oxygen
status (Figure 2.6C and 2.6E). These data may indicate a role for dHIFα in the insulin
receptor pathway. Numerous studies demonstrate that trehalose levels are altered by
genetic disruptions of the insulin-signaling components (144–147). Alternatively,
elevated trehalose levels may be the result of constitutively high expression of amylase
(Figure 2.6D). Although the increased amylase expression does not translate into a
depleted level of glycogen in the sima mutant (Figure 2.6A), it is conceivable that
increased glycogen deposition compensates for increased glycogenolysis.
It is important to note that post-transcriptional control mechanisms are well known to
impact glycolytic enzymes. Although we did not document them, we consider such
influences on hypoxic glycolytic flux likely to have genotype-specific effects.
sima mutants do not mobilize glycogen in hypoxia, but they are able to initiate Hinduced changes for other carbohydrates. This is the case for the glycolytic intermediate
DHAP, which more than doubles in a control hypoxic response and significantly
accumulates in mutants (Figure 2.6C, 2.6E). These findings are consistent with
appropriate transcriptional responses we noted for glycolytic transcripts in sima animals,
which are up-regulated in hypoxia by dERR, not dHIFα. The result for glycogen
notwithstanding, it is the widespread derangement of normoxic set points for metabolites
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that characterizes the metabolic incompetency of the sima mutant. Our data indicate that
dHIFα has it greatest impact on metabolism in the unchallenged normoxic state, rather
than in hypoxia.
The mechanism whereby dERR participates in hypoxic responses needs to be
explored further. We identified dERR as a potential player in hypoxic responses through
its association with dHIFα (Figure 2.8A), suggesting that it acts in a collaborative role
with the HIF complex through direct recruitment to HREs. This model was favored by
the Ao et al. report for ERR participation in hypoxic responses in vertebrates (68).
Additionally, dERR may recruit dHIFα to ERR-specific response elements to facilitate H
responses. Another possibility is that dERR actively regulates hypoxic transcription
without dHIFα at all; or, in parallel to the actions of dHIFα, which may occur
independently, yet simultaneously. Each of these scenarios is consistent with hypoxic
expression analysis that we performed to generate HD, HI, ED, and DM gene sets.
Moreover, in the presence of dERR, dHIFα may act as a negative regulator of hypoxic
responses at select hypoxia-regulated sites (Figure 2.10E, NMNAT, ALAS). Of further
interest also, will be the identification of the triggers for ERR participation in hypoxicinduced responses.
Apart from dERR and dHIFα, our data indicate that at least one more hypoxicsensitive pathway is active and important for mediating hypoxic adaptation, as we found
many H-sensitive transcripts that fall outside the regulation of either factor. The nature of
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the alternate pathway(s) is unknown. The results shown here suggest that identifying the
sensors and effectors that regulate these HIF- & ERR-independent hypoxic response
pathways will have profound impacts on our understanding of hypoxic signaling, and will
undoubtedly provide new avenues with which to approach the complex problem of
metabolic transition.

CHAPTER 3 The ERR Regulates an Atypical Acyl-CoA Synthetase (CG4500) in
Drosophila melanogaster

3.1 Introduction
Multicellular organisms from Drosophila to mammals need to coordinately maintain
system-wide balance between cellular energy consumption and storage. Excessive
metabolic consumption or storage will result in devastating consequences. In modern
society, due to the advanced development of agricultural and animal husbandry, the
contemporary human diet features an overabundance of fat, simple sugars, sodium and
chloride, but also accompanies a scarcity of fiber, calcium and potassium (148). This kind
of modern diet causes excessive energy storage and subsequent disturbance of lipid
metabolism, which is tightly associated with metabolic syndrome that becomes a growing
public health concern worldwide. Metabolic syndrome is a group of metabolic
abnormalities including obesity as the central factor, as well as hypertension,
dyslipidemia (decreased high-density lipoprotein, and elevated serum triglycerides),
impaired fasting glucose (type 2 diabetes), and subsequent heart disease (149 - 151).
Notably, the prevalence of metabolic syndrome in the United States is over 35% by two
separate defining standards, the adult treatment panel (ATP) and the international
diabetes federation (IDF) (152). Overall it is hard to overstate the importance of
67
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understanding the molecular mechanism underlying all aspects of lipid storage,
mobilization, and oxidation.
Fatty acids (FAs) are a major component of lipids, and key source of high efficiency
ATP production through oxidation degradation. FAs are a group of carboxylic acids with
a long aliphatic chain, which is either saturated or unsaturated. According to the length of
the aliphatic tail, FAs can be categorized as short-chain fatty acids (SCFAs) with chain
length of 6 carbons or less, medium-chain fatty acids (MCFAs) with 6 to 12 carbons,
long-chain fatty acids (LCFAs) with 14-22 carbons, and very-long-chain fatty acids
(VLCFAs) with aliphatic tails longer than 22 carbons. FAs with less than 14 carbons or
more than 20 carbons are uncommon, and the predominant FAs in mammals are those of
the C16 and C18 species (153). Fatty acid catabolism is a multi-step process. Generally,
excess energy is stored in the form of triglycerides (TGs). When energy is needed
somewhere in the body, free FAs are initially mobilized from TGs through the activity of
lipases. Free FAs can be degraded by several cellular pathways, including α-, β-, and ωoxidation. In humans, α- and ω-oxidation can only occur in peroxisomes, but both
peroxisomes and mitochondria are capable of catabolizeing FAs through β-oxidation.
However, the favored path for FAs, including the majority of LCFAs, is through
mitochondrial β-oxidation (mβ-ox) (154). Unlike MCFAs that freely penetrate the
mitochondrial membrane, LCFAs have to be transferred by means of a carnitine cycle
into mitochondrial matrix, where β-oxidation occurs. LCFAs have to first be activated by
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coupling to Coenzyme A (CoA) by the acyl-CoA synthetase (ACS) family of enzymes on
the mitochondrial outer membrane. The CoA group of the fatty acid-CoA molecule (acylCoAs)

is

next

replaced

by

carnitine

to

form

acylcarnitines

by

carnitine

palmitoyltransferase І (CPT-І). The long-chain acylcarnitines are then exchanged and
translocated into the mitochondrial matrix by an integral inner membrane protein,
carnitine-acylcarnitine translocase (CAT). Finally, the long-chain acylcarnitines in the
mitochondria matrix are converted back to long-chain acyl-CoA by carnitine
palmitoyltransferase II (CPT-II) on the inner mitrochondrial membrane. At last, the
liberated carnitine is exchanged back to mitochondrial outer membrane and LCFAs are βoxidized to yield acetyl-CoA, which will enter TCA cycle to generate energy (Figure
3.1A) (153). Essentially, the carnitine cycle is the barrier for LCFAs mβ-ox, because
without it LCFAs are not able to go into the mitochondria. And it is not surprising that
CPT-I is considered to be the rate-limiting step and a key regulatory site of mβ-ox.
Noteworthy, in addition to mβ-ox, there are also other alternative routes for fatty acid
oxidation (α-, β-, and ω-oxidation in peroxisome) (154). FA α-oxidation only occurring
in peroxisomes is a process by which 3-methyl-branched-chain FAs like phytanic acid are
broken down by removal of a single carbon from the carboxyl end. Compared to mβ-ox,
peroxisomes β-oxidation (pβ-ox) is catalyzed by different enzymes encoded by distinct
genes. Importantly pβ-ox breaks down a distinct set of FAs, such as VLCFAs, and di/trihydroxy acid (155). However, pβ-ox is not capable of complete oxidation, but
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Figure 3.1 A scheme of the conversion of LCFAs into ATP in the mitochondria.

rather truncates the FAs to lengths that can enter the mitochondrial matrix without the
need for carnitine, and eventually these chain-shortened FAs are fully oxidized in
mitochondria. FA ω-oxidation occurs in the endoplasmic reticulum (ER). The ω-carbon
in FAs is the carbon furthest in the alkyl chain from the carboxylic acid, which is
progressively oxidized first to an alcohol and then to a carboxylic acid, creating a
molecule with a carboxylic acid on both ends in ω-ox. Eventually, the resulting
dicarboxylic acids will enter pβ-ox to be catabolized (154). Notably, α- and ω-oxidation
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of LCFAs, coupled with pβ-ox, can be vital alternate routes for humans or animals that
cannot rely on mβ-ox of FA oxidation, such as CPT-I deficient patients.
Fatty acid catabolism is regulated in many ways. As the rate-limiting step of mβ-ox,
CPT-I activity is strictly regulated. Most importantly, it is potently inhibited by the
concentration of malony-CoA. The formation of malony-CoA is catalyzed by acetyl-CoA
carboxylase (ACC), the activity of which is acutely inactivated or activated by
phosphorylation and dephosphorylation, respectively (156). The phosphorylation is
achieved by 5’-AMP-activated kinase (AMPK)/AMPK-kinase cascade (157). In addition,
the expression of CPT-I is also regulated at the transcriptional level by fatty acid
concentration. The transcriptional regulation of fatty acids on CPT-I is very likely
mediated through PPARs. A PPRE is found in the regulatory region of the human muscle
type CPT-I gene (158). Another study showed that in primary rat neonatal cardiac
myocytes, CPT-I mRNA levels are stimulated by oleate through PPARα (159).
Fatty acids catabolism is also regulated through other sites other than CPT-I. The
highly conserved insulin/IGF signaling (IIS) pathway is a critical regulator of lipid
homeostasis, although the molecular mechanisms by which IIS controls lipid catabolism
are only understood in part (160). It has been found that IIS is able to inhibit both
expression and activity of lipases (161, 162). Furthermore, IIS also decreases the rate of
fatty acid entry into mitochondria partially through FOXO action (163, 164).
Interestingly, a recent study conducted in Drosophila identified an unconserved ACS,
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pudgy, is direct target gene of FOXO in the fly. They also found that in mammalian cells
multiple ACSs are regulated by insulin signaling at the transcriptional level (165).
Importantly, this study identified fatty acid activation by ACSs as an important, regulated
step in FAs oxidation, which has not been considered as a key step in FAs oxidation
regulation. Furthermore, NRs and their co-partners, as discussed in Chapter one, are also
important regulators of FAs catabolism. PPARs not only directly regulate the expression
of CPT-I, but also transcriptionally regulate a broad range of genes involving in many
aspects of fat catabolism, such as FAs uptake through membranes, intracellular fatty acid
trafficking, FAs oxidation and ketogenesis, and triglyceride storage and lipolysis (166).
PGC-1α/β regulate many steps of mitochondrial oxidative metabolism coordinately with
lots of transcription factors, including mitochondria biogenesis, OXPHOS, CPT-I
expression, FAs oxidation genes, glucogenesis and lipogenesis (167).
Importantly, as discussed extensively in Chapter one, ERRs not only function as a
master regulator of almost all aspects of metabolic processes, including glycolysis, FAs
oxidation, mitochondrial biogenesis and mitochondrial function (the TCA cycle and
OXPHOS), but also likely serves as a switch to metabolic transitions. However, the
studies concerning the regulation on FAs catabolism have not focused on the ACS
activation of LCFAs, except the one study that showed that the IIS pathway regulates
ACS mRNA expression in both fly and human cells (165). This study provides a new
perspective that the master regulator of metabolism, ERRs, may transcriptionally regulate
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the expression of ACS genes and control the FAs flux into mitochondria in order to
manipulate FAs catabolism.
To test this hypothesis, we utilize Drosophila development as a platform to
investigate lipid oxidation pathways. As discussed previously, the major metabolic
processes are very much conserved in Drosophila, compared to mammals. Interestingly,
Drosophila undergoes a programmed Warburg like transition in late embryogenesis (87),
but strikingly they turn off the Warburg effect just before metamorphosic onset. These
two metabolic switches correspond to the developmental profile that Drosophila
experience. Figure 3.2 illustrates that flies accumulate lipid from L1 until partial clear gut
stage (-10 to -4 hour before pupariation), when in preparation for metamorphosis, larvae
finish their growth phase, leave the food, and start a starvation period initiating at the
wandering stage and lasting through the pupa stage, which results in a dramatic depletion
of fat stores (Figure 3.2). The majority of the liberated FAs are LCFAs, and at this
developmental stage the main forms of FAs are myristic acid (14:0), 13.3% of total lipid;
palmitic acid (16:0), 24.4% of total; palmitoleic acid (16:1), 24.9% of total; and oleic acid
(18:1), 30.8% of total (168). This observation suggests that flies must trigger mβ-ox
during this developmental starvation period in order to generate energy to survive. Since
the previous study done by Tennessen et al. found that in L2 larvae dERR targets the
transcription of glycolysis enzymes rather than enzymes involved in FAs catabolism, we
reasoned to make the following hypothesis that dERR is very likely to transcriptionally
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regulate FA oxidation at the wandering stage when FAs need to be degraded to produce
enough energy for the larvae to survive. In this Chapter, we identify CG4500 as an ACS,
which is strongly up-regulated upon fasting in a stage-dependent manner. We find
that the expression of CG4500 is almost completed abolished in dERR mutant animals,
and CG4500 is likely to be a direct target of dERR. Furthermore, we show that the dERR
mutant is deranged in fatty acid oxidation with dramatically reduced levels of carnitine
conjugates of LCFAs and elevated levels of all MCFAs and LCFAs in the C10-15 range.
These results suggest that dERR is highly likely to direct the second metabolic switch
toward FAs catabolism in late-L3.

Figure 3.2 The profile of body weight and lipid percentage through Drosophila
development. The mass (black line) and % lipid (blue line) of Drosophila melanogaster
plotted with respect to developmental progression. L = instar, PP = prepupa.
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3.2 Methods
3.2.1 Fly strains, developmental collection and starvation treatments
Flies were maintained on regular cornmeal-molasses-yeast media at 25°C.
w1118 animals were treated as controls. dERR mutants (dERR1/dERR2) are described
elsewhere (87). The dERR1 and dERR2 chromosomes were carried over a TM3, twi-GFP
(green fluorescent protein) balancer chromosome. Homozygous mutant larvae were
sorted for the absence of GFP expression using a Zeiss Discovery V.8 dissecting
stereoscope with fluorescence at developmental stage between 12hr AEL and mid-L2.
For collecting the clear gut L3, embryos were collected at 25°C for 14 hrs onto egg caps
(molasses-agar media in 35 mm×10 mm dishes) with yeast paste. Then mid-L2 larvae
were either sorted for green fluorescence (dERR mutant) or not (wild type), and
transferred to a fresh egg cap with blue yeast paste (0.3% bromophenol blue), and
allowed to develop until achieving the clear-gut L3 stage (−4 to 0 hrs RTP). For
developmental analysis of gene expressions, 12 developmental stages were collected in
w1118 animal: 6-12 hr AEL, 12-18 hr AEL, 18-24 hr AEL, 0-6 hr L1, mid-L1, mid-L2,
mid-L3, -4 to 0 hr RTP (relative to pupariation) L3, 6 hr RTP, +18 hr RTP, +72 hr RTP,
and 1-day old males. For starvation treatment in Figure 3.5, mid-L2 of w1118 or
dERR1/dERR2 allowed to grow on egg cups as described earlier with yeast paste were
sorted for green fluorescence (mutant) or not (wild type), and transferred to a) new egg
cups with yeast paste for control; b) kimwipe paper with water for complete starvation, or
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c) kimwipe paper with 20% sucrose in water that was sterilized by filtering, treated for 8
hours. For 1-day male starvation experiment, w1118 larvae grow on egg cup with yeast
paste as described earlier until pupariation, and then pupae were transferred to regular
cornmeal-molasses-yeast media until emerge. 1-day old males were picked and treated
with a) regular cornmeal-molasses-yeast media; b) kimewipe with water, or c) 20%
sucrose prepared as described in this paragraph, treated for 24 hours. All treatment
experiments were carried out at 25°C.

3.2.2 Microarray analysis and Quantitative RT-PCR
Microarray analyses were performed on at least three biological replicates
of w1118 animals and dERR mutants at the lear-gut L3 stage. For each biological replicate,
at least 10 larvae were collected and washed with 1×PBS before homogenization in
TRIzol (Invitrogen, Carlsbad, CA) using a VWR disposable pellet mixer. RNA
preparation and microarray analysis were done as described in Chapter 2 Section 2.2.2.
No changes below 1.5-fold were considered significant. Additionally, the following false
discovery rate percentages were imposed: <1% w1118 vs dERR mutant. Microsoft Access
was used to compare data sets.
For qRT-PCR analysis, cDNA samples were prepared as described in Chapter 2
Section 2.2.3. For real-time PCR, premixed primer-probe sets were purchased from
Applied Biosystems. Experimental values were normalized to values obtained for
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the Rp49 probe set. Data are reported as the mean±SEM. All values reported represent
experiments performed on at least three biological replicates.

3.2.3 Assay for ACS activity
His-tagged luciferase protein was obtained by cloning the coding sequence into
pET16b, expressing it in BL21 E. coli, and purifying it using Ni-NTA Agarose beads
(Thermo Fisher Scientific, Waltham, MA). GST-tagged CG4500 protein was obtained by
cloning the cDNA sequence into pGEX 4T1, expressed in BL21 E.coli, and purified
using glutathione sepharose 4 fast flow beads (GE Healthcare & Life sciences). Purified
GST protein was generally given by Dr. Jessica Bell from Department of Biochemistry
and Molecular biology of VCU. All FAs (decanoic acid C10:0, lauric acid C12:0,
palmitic acid C16:0, palmitoleic acid C16:1, stearic acid C18:0, oleic acid C18:1,
arachidic acid C20:0, cerotic acid C26:0) used in this study were obtained from SigmaAldrich (St. Louis, MO). All FAs, except cerotic acid, were dissolved in DMSO, aliquot
and stored in -20˚C. Cerotic acid was dissolved in chloroform and stored as other FAs.
Adenylation activity for carboxylic acids were carried out as previously described
with modification (169). Instead of 50nM of enzyme, 500nM of enzymes were used in
our assay. Instead of 0.33µCi, 1.266µCi of [α-32P]ATP was utilized here. The TLC plates
were developed in Chloroform/Acetone/Methonal/Acetic acid/H2O (5:4:3:2:1). The
radioactivity of

32

P-AMP was measured using a phosphoimager (Molecular Imager FX,
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Bio-Rad, Hercules, CA) after exposing overnight. Relative intensity of the radioactivity
was obtained by subtracting the background value. The concentration of DMSO and
chloroform at 2% in the reaction did not affect the activity (data not shown).

3.2.4 Metabolic analysis by GC/LC-MS
Analyses were performed on clear-gut L3 larvae of w1118 and dERR1/dERR2animals.
Larvae were washed twice in PBS pH 8.0 and immediately frozen at −80°C. The GC/LCMS analyses and the data analysis method were performed by Metabolon, Inc. (Durham,
NC) and extensively described in Chapter 2 section 2.2.4.

3.3 Results
3.3.1 An uncharacterized acyl-CoA synthetase, CG4500, is down-regulated in dERR
mutant animals.
Previously, it had been shown that dERR mutants are unable to initiate the
metabolic transition toward aerobic glycolysis to drive biomass production for
developmental growth of the larva (87). The phenotypes that were observed in dERR
mutant mid-L2 larvae were overwhelmingly associated with defects in carbohydrate
catabolism, shockingly with little effect on fat catabolism (data not shown and 87). As
discussed repeatedly, Drosophila larvae need to accumulate fat before the wandering
stage, which starts around 24 hours before pupariation. Although only about 48 hrs apart
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from mid-L2 in developmental timing, late-L3 animals undergo a very different
metabolic plan. We speculated that dERR is likely involved in transcription regulating
the late larval-switch toward OXPHOS. To test this hypothesis, we performed microarray
analyses on RNA from clear-gut L3 larvae of control (w1118) animals and dERR mutant
(dERR1/dERR2). Clear-gut larvae are in a tight developmental window that is 0-4 hrs
prior to pupariation. It takes 14-18 hrs of wandering for larvae to reach clear-gut status.
They have been in developmental starvation for quite some time and are rely on fatderived ATP generation. Although the lipase expression is not changed in dERR mutant,
encouragingly, we found the expression of several enzymes involved in LCFAs
activation are altered significantly (Table 3.1). The most interesting transcript was an
uncharacterized gene CG4500, which is predicted to be an acyl-CoA synthetase. The
transcriptional expression of CG4500 is down-regulated 8 times in the dERR mutant,
which is among the top ten most down-regulated genes in all transcripts tested (data not
shown, Table 3.1). CG4500 encodes for an atypical bubblegum-like ACS in Drosophila,
and is closely related to bubblegum protein in fly (44%), which is an ACS acting on
VLCFAs (C22-26) and prevents their build-up (170). However, the human homolog of
CG4500 is ACSBG2 that is an ACS acting on oleic acid (C18:1) and linoleic acid
(C18:2) but not on other FAs tested (171). Interestingly, a human homolog of bubblegum
(ACSBG1) can catalyze both LCFAs and VLCFAs (172).
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Table 3.1 Transcriptional fold-changes measured by microarray in dERR mutants vs.
w1118 control animals of LCFA metabolic transcripts at clear-gut L3 larvae
CG

Gene Name

Fat Mobilization (ATGL)
CG5295
brummer lipase
LCFA Activation (ACS)
CG8732
ACS long-chain
CG4501
bubblegum
CG12512
--CG18155
--CG3961
--CG4500
--CG6178
--CG9009
pudgy
Carnitine Palmitoyltransferase (CPT)
CG12891
CPT I
CG2107
CPT II
CG1041
--Acyl Carnitine Transporter (CAT)
CG3057
Colt
CG3476
--CG12201
--CG3790
--CG4630
--CG6006
--CG8925
---

Fold Change in dERR mut
1.00
1.67
4.05
3.22
-1.52
-1.18
-8.03
2.77
-1.37
-1.86
1.19
1.59
1.21
1.29
-1.30
1.16
1.35
-1.11
-1.92

3.3.2 dERR is critical in the programmed expression of Pfk and CG4500
To further test the possibility that dERR turns on the early metabolic switch toward
glycolysis during late embryogenesis, and later initiates a switch toward fatty acid
oxidation before pupariation, we examed the expression profile of two representative
metabolic enzymes through development. We collected RNA from control animals
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and dERR mutants at 12 stages of development, including 6-12 hr AEL, 12-18 hr AEL,
18-24 hr AEL, 0-6 hr L1, mid-L1, mid-L2, mid-L3, -4 to 0 hr RTP (relative to
pupariation) L3, 6 hr RTP, +18 hr RTP, +72 hr RTP, and 1-day old males. qRT-PCR was
used to assess the relative expression of two genes, Pfk and CG4500. Pfk is the ratelimiting enzyme of glycolysis, and as the detector for glycolytic catabolism. CG4500, as
shown earlier, is highly likely to be a LCFA ACS, and serves as the indicator for FAs
oxidation. Strikingly, we see that the Pfk mRNA amounts dramatically increase from the
embryonic stages through mid-L3, when its expression level reaches maximum, and is
followed a sharp drop in expression at wandering onset. Thereafter, it is expressed at a
low level until adulthood (Figure 3.3 A). In contrast, the CG4500 mRNA amounts is low
from the embryonic stages through clear-gut L3, when its expression increases
dramatically and reaches its peak at +18 hr RTP, which is followed by a gradual decrease
in metamorphosis, where finally go back to the expression level of the late embryo in
adult fly (Figure 3.3 A). Even more strikingly, the expression of Pfk and CG4500 are
both almost completely abolished in dERR mutant at times, when their expression is still
increasing (mid-L2 for Pfk and clear-gut L3 for CG4500). Collectively, these data
suggest that dERR is likely instrumental in the late larval switch toward FAs oxidation,
essentially countering its earlier pro-glycolytic activities.

82

Figure 3.3 qRT-PCR analysis reveals that Pfk and CG4500 exhibit dynamic
expression through development (A). dERR is required for the pro-growth glycolytic
program, represented by Pfk (B), and for the late-larval shift to FAs oxidation,
represented by the long-chain fatty acid acyl-CoA synthetase, CG4500 (C). Collection
times for B and C are noted by *.

3.3.3 CG4500 is an ACS with catalytic specificity on MCFAs and unsaturated LCFAs.
Each ACS has distinct substrate specificity, loading FAs of different lengths or
saturation onto CoA. To determine the substrate specificity of CG4500, an acyl-CoA
synthesis assay was performed using a series of FAs, including a variety of MCFAs,
LCFAs, and VLCFA. Here, firefly luciferase is utilized as a positive control for the assay.
It was previously shown that luciferase of P.pyralis and L.cruciata displayed significant
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acyl-CoA synthetase activity on a variety of FAs, including saturated MCFAs (C10:0,
C12:0), saturated LCFAs (C14:0), unsaturated LCFAs (C16:1, C18:2, C18:3n-3, C18:3n6, C20:4, and C20:5) (169). Purified GST protein was used as negative control. Since we
use radioactive labeled [α32-P]ATP, recombinant enzymes purified by affinity column
were employed in order to avoid high background associated with whole cell extract.
Figure 3.4C showed that all three recombinant proteins are relatively pure with > 90% of
purity, and, indeed, we see very low or almost no background. As expected, firefly
luciferase of P. pyralis exhibits substrate specificity on C10:0, C12:0, C16:0, C16:1,
C18:1, which is in accordance with the previous findings (Figure 3.4A and B, and 169).
Furthermore, CG4500 acts on both saturated MCFAs and unsaturated LCFAs, including
C10:0, C12:0, C16:1 and C18:1 (Figure 3.4A and B). The substrate specificity of
CG4500 on C16:1 and C18:1 is encouraging, because its human homolog, ACSBG2,
preferentially acts on unsaturated LCFAS (oleic acid (C18:1) and linoleic acid (C18:2)),
but not on palmitic acid (C16:0) and linoceric acid (C24:0) (171), suggesting a conserved
modality of preference is maintained from Drosophila to humans. However,
unexpectedly, we observed that CG4500 has higher catalytic activity on MCFAs than on
LCFAs. As we discussed in Section 3.3.1, CG4500 is most similar to enzymes that either
ACS of LCFAs or VLCFAs; we did not expect it to act on MCFAs. Although CG4500
prefers MCFAs over LCFAs as substrates, because the lipid content of the fat body is
overwhelmingly long-chain-triglyceride, it likely still acts mostly on LCFAs.
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Figure3.4 Substrate specificity of CG4500. A) and B) Fatty acyl-CoA synthetic activity
was determined by the formation of acyl-adenylate from a series of FAs. Fatty acyladenylate formation was monitored by detection of released 32P-AMP from [α-32P]ATP
with TLC analysis. A) shows the TLC scan from Phosphoimager and B) shows the
relative activity for each enzyme that is expressed as a percentage with respect to lauric
acid. Assays for each FA independently repeated three times and the data represent the
means ± SEM. C) Three recombinant protein purified by affinity column were separated
by SDS-PAGE. 2.5mg of protein was run for each sample. Abbreviations are as follows:
C10:0, decanoic acid; C12:0, lauric acid; C16:0, palmitic acid; C16:1, palmitoleic acid;
C18:0 stearic acid; C18:1, oleic acid; C20:0, arachidic acid; C26:0, cerotic acid; Luc,
luciferase protein; GST-CG4500, GST tagged CG4500 protein.)
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3.3.4 CG4500 expression is induced by water starvation in a temporal-specific fashion.
Next, we wanted to know whether CG4500 expression could be uncoupled from the
developmentally orchestrated induction (Figure 3.3A) and induced by starving animals at
developmental times that reach metabolic homeostasis, such as 1-day old males. And,
was dERR required at other times? To begin, we tested two different time points, young
larvae (at mid-L2) and young adult males (1 days post eclosion) by total nutrient
deprivation (H2O) or through sugar-only feeding (20% sucrose) for an 8-hr period for
mid-L2 and 24-hr period for adult fly, and we compared transcriptional responses to
animals on a normal diet (yeast for mid-L2 and regular cornmeal-molasses-yeast media
for adult males) by qRT-PCR. Because dERR mutants do not survive to adulthood we
were only able to assay responses in the w1118 control. In addition to CG4500, we also
looked at CPT-I responses, reasoning that CPT-I may have a similar profile, because it
should be active at the same time as CG4500. We found that the expression of CG4500 is
highly sensitive to starvation in young adults (Fig. 3.5A). Interestingly, this induction
depends upon a depletion of sugar specifically, as the sucrose-supplemented animals
remained unresponsive. We also found that, unlike CG4500, CPT-I was induced (albeit
to a lesser extent) in animals fed only sugar, which was similar to the H2O response (Fig.
3.5B). These results indicate that CG4500 and CPT-I are likely controlled through
separate nutrient-sensing pathways. In contrast to young adults, young larvae downregulated CG4500 expression in response to limiting nutrient conditions, regardless of
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genotype (Fig. 3.5C). This response was specific to CG4500, because CPT-I responded
as it did at the later adult time, showing modest induction in the control animals (Fig.
3.5D). However, in the dERR background CPT-I was not induced, but it did have a much
elevated basal expression that was over 10-fold higher than control animals. This
phenomenon suggests that dERR not only promotes glycolysis in early Drosophila
developmental, but also might suppress oxidation of FAs at that time.

Figure 3.5 The triggers for induced expression of CG4500 and CPT-I are different
and temporal-specific. Induction of CG4500 in day-old control males (A) on water
alone but not those fed 20% sucrose, while both conditions elicited similar responses for
CPT-I (B), though water was not significant. In mid-L2, CG4500 was repressed in both
control and dERR mutants (C), while control animals induced CPT-I in limiting nutrients
and dERR mutants showed no change, but had elevated basal (D). Starvation challenges
were carried out for 8 hrs for L2 and 24 hrs for adult. Responses measured by qPCR. * =
p-value < 0.05. Error bars are ±SEM.
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3.3.5 dERR mutant clear-gut L3 larvae are deranged in FAs metabolism.
We have shown that dERR regulates the expression of CG4500, which is an acylCoA synthetase acting on MCFAs and unsaturated LCFAs, just prior to metamorphosis.
We next wanted to test whether this regulation has an effect on metabolism in dERR
mutant. To do this, we measured a host of metabolites by GC/MS and LC/MS/MS in
control (w1118) animals and dERR mutants (dERR1/dERR2) in extracts that were prepared
from clear-gut L3 larvae, the same stage of which our microarray analyses were
performed. We found that dERR mutants are fully competent to mobilize stored fat from
triacylglyceride (TAG) stores (Figure 3.6A). Furthermore, they have normal or elevated
levels of all LCFAs surveyed, and have elevated levels of all medium-chain FAs
measured, with particularly high levels of FAs in the C10-15 range (Figure 3.6A). These
results suggested that TAG lipase activity was likely not affected in this background,
especially since pre-wandering TAG levels were not significantly different in control and
mutant animals (data not shown). These results also correspond to the unchanged
expression of brummer lipase in dERR mutants. In contrast, carnitine conjugates of
LCFAs were dramatically reduced altogether, despite having elevated levels of free
carnitine available and a two-fold increase in deoxy-carnitine, a marker for carnitine
synthesis (Figure 3.6B). These collective results indicated that dERR mutants are unable
to process LCFAs for mβ-ox at the outer mitochondrial membrane.
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Figure3.6 dERR mutants are disturbed in lipid metabolism in clear-gut L3 larvae.
Altered free fatty acids levels A) and carnitine species B) in dERR mutants as
determined by GC/MS and LC/MS/MS. Dotted line shows levels for metabolites in
control background. * = p-value < 0.05. Error bars are ±SEM.
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3.4 Conclusions and Discussions
Here, we identified an uncharacterized acyl-CoA synthetase CG4500, the expression
of which is under regulation of dERR right before metamorphosis in Drosophila. We
showed that CG4500 specifically catalyzes the activation of saturated MCFAs (decanoic
acid C10:0 and lauric acid C12:0) and unsaturated LCFAs (palmitoleic acid C16:1 and
stearic acid C18:1) (Figure 3.4). In addition, microarray analysis and qRT-PCR
experiments both showed that dERR mutants have very low-level expression of CG4500
transcripts in clear-gut L3 larvae (Table 3.1 and Figure 3.3). The regulation of dERR on
CG4500 could be direct or indirect, however, our evidence favors that it is of a direct
nature and that dERR binds to the promoter region to facilitate CG4500 transcription.
Firstly, as a transcription factor mammalian ERRs are generally recruited to an ERRspecific response element (ERRE), which is a consensus sequence of AGGTCA as the
core motif preceded by a TNA flank (173). We have found multiple potential ERREs (the
core element AGGTCA) located in 5 kb upstream of CG4500 translation start site.
Furthermore, there is an ERRE with high fidelity to the consensus sequence
(TCAAGGTCA) located in the second intron of CG4500, which is conserved in several
Drosophila species. More importantly, although we have not examined direct binding
between dERR and the CG4500 promoter in our lab, a consortium performed CHIP-Seq
analysis, and their data suggests that ERR localizes with great enrichment to the CG4500
prompter at three developmental times, including mid/late-embryos and early wandering
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L3 (Figure 3.7). In addition, we are in the progress of completing directed CHIP
experiments to test the interaction between dERR and the genomic region of CG4500,
and identify the dERR regulatory sequence of CG4500 using luciferase reporter gene
assay.

Figure 3.7 ERR-GFP is highly enriched at the CG4500 promoter in mid/late-embryo
and early wandering L3. ERRE is indicated by the marked blue line.

Studies of the regulation of FA oxidation has been focused on the step of free FAs
liberation (lipase) and the activity and expression of CPT-I considered as the rate-limiting
step in lipid oxidation. Nevertheless, emerging evidence has revealed steps other than
lipolysis and the carnitine cycle is important regulated events in the fatty acid catabolic
pathway. For example, a recent report demonstrated that PGC-1/ERRα axis is involved in
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the transcriptional regulation of CAT (carnitine/acylcarnitine translocase), which could
be induced by fasting in mouse skeletal muscle (174). Another study which shares great
similarity with our study here revealed that the coupling event of fatty acids to CoA via
ACSs is an additional important regulated step in lipid catabolism in both fly and
mammals (165). Intriguingly, the ACS (pudgy) identified in the study performed by Xie
et al. is an unconserved gene that is only expressed in Drosophila. They observed pudgy
is transcriptionally regulated by insulin/IGF. Interestingly, they found that the regulatory
relationship between insulin/IGF and ACSs is preserved in mammalian cells, even though
the regulated ACS is not conserved (165). The mammalian homolog of the ACS CG4500
we identified is called acyl-CoA synthetase bubblegum family member 2 (ACSBG2).
ACSBG2 is primarily expressed in brainstem and testis (171), but not in adipose tissue,
liver and muscle. This may raise the concern that the regulation of dERR in lipid
oxidation at the level of CoA activation is not applicable to the mammalian system.
However, there are two considerations to ease this concern. Firstly, although we did not
demonstrate whether the lipid metabolism is disturbed or not in CG4500 mutant animals
due to the availability of the animals, we showed that CG4500 expression is potently
induced by starvation, either developmental or applied (Figure 3.3 and Figure 3.5).
Additionally, data posted online at flyatlas.org done by Dow et al. shows tremendous
enrichment of CG4500 expression in the late-L3 fat body relative to any other tissue
sampled (175). Fat body is considered as adipose tissue and liver counterpart for flies.

92

These data suggest that the expression of CG4500 is subject to regulation of nutrition
status. Secondly, as mentioned earlier in this paragraph, the regulation relationship rather
than the specific molecules seems to be preserved cross spices. We plan to perform
starvation experiments in a mammalian adipocyte cell line (3T3-L1) with or without
ERRs inhibitor, and examine mRNA level of multiple ACSs, including ACSBG2, by
qRT-PCR. Hopefully, these experiments will firmly establish the regulatory role of ERRs
on lipid oxidation at the level of fatty acid activation. This new link may be a potential
target for drug development for variety of metabolic syndromes.
We observed that dERR mutants have imbalanced lipid profile. In clear-gut L2
larvae, they have depleted levels of carnitine conjugated LCFAs (acetyl-carnitine,
myristoyl carnitine, palmitoyl-carnitine, stearoyl-carnitine, oleoyl-carnitine), but elevated
MCFAs (nonanoic acid C9:0, decanoic acid C10:0, lauric acid C12:0, lauroleic acid
C12:1) and LCFAs with carbon between 14 and 20 (myristic acid C14:0, myristoleic acid
C14:1, pentadecanoic acid C15:0, 10-heptadecanoic acid C17:1, 10-nonadecanoic acid
C19:1) (Figure 3.6). One phenomenon that draws my attention is the much increased
MCFAs level in dERR mutant animals. As we know, MCFAs can freely penetrate the
mitochondria (153). They do not need activation of ACSs or carnitine conjugation as for
mβ-ox. If CG4500 is the only lipid metabolic enzyme greatly affected in dERR mutant,
then MCFAs should not be significantly altered due to the fact that they can still travel
into the mitochondria. So this data really suggests that other than CG4500 dERR
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probably regulates other enzymes involved in lipid oxidation pathways. Indeed, a
mammalian study showed that ERRα transcriptionally regulates the human mediumchain acyl CoA dehydrogenase, which is the enzyme catalyzes the first step of MCFA βoxidation (173). So without this enzyme, MCFAs cannot be break down through βoxidation to generate energy. Interestingly, our preliminary result from the microarray
analysis done on wild type and dERR mutant of the clear-gut L3 exhibits decreased
expression level of CG12262, which is a probable medium-chain specific acyl-CoA
dehydrogenase (data not shown). As the master regulator of metabolic network, in my
opinion, it is not shocking that ERR has multiple gene targets no matter in flies or
mammals. These findings encouraged us to perform careful analysis on other metabolic
enzymes that might be under the control of ERRs, which may provide insights to research
performed in other organisms.
Last but not the least, currently we have not been able to measure the level of
malonyl-CoA, which can inhibit CPT-I and have the same effect as CG4500 depletion.
We want to rule out the possibility that the decreased levels of carnitine-conjugated FAs
in dERR mutant is a consequence of abnormally high level of malonyl-CoA. We plan to
reduce the level of malonyl-CoA by reducing the level of acetyl-CoA carboxylase (ACC)
that converts acetyl-CoA to malonyl-CoA using an available RNAi construct. We
consider elevated ACC activity highly unlikely, because we saw that AMPK, which is a
potent inhibitor of ACC activity (176), is constitutively activated in dERR mutants (data
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not shown). If knockdown of ACC does not affect the LCFA metabolites in dERR
mutants, than almost for sure malonyl-CoA is not the problem.

Chapter 4 Conclusions and Future Directions

Metabolic homeostasis is strictly regulated and subject to instant changes under many
physiological and pathological conditions, including normal development, where
metabolism undergoes approximately series of physiologic changes, in cancer, where a
pathological metabolic profile drives physiology, and in hypoxia, as both physiological
and pathological conditions control outcomes. Normally, multicellular organisms have
limited nutritional uptake, and in that way they need to employ a strategy to produce ATP
efficiently. However, in some situations, such as development or hypoxia, cells rely on
atypical metabolic strategies that are not necessarily efficient. For example, hypoxic
metabolism heavily leans on glycolysis and converts pyruvate to lactate. Interestingly,
proliferating cells also shift metabolism from mitochondrial OXPHOS toward glycolysis
and lactate generation too, but for a different reason. They need to generate building
blocks to provide all the materials for growth as we discussed in Chapter 1.
Our primary goal was to better understand the triggers cells employ and the
consequences for different strategies of bioenergetic metabolism, using Drosophila as a
model. Drosophila can respond robustly to hypoxia, and they also experience two
programmed metabolic transitions through their development, making them a good
model for our studies. Here, we also found that hypoxia-induced adaptation is stage
dependent. We saw that hypoxic transcriptional induction is most apparent at the late-L3
95
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time for all genes assayed. Our findings are consistent with previous observation that
transient hypoxic exposures during the late larval and early pupal stages had the
maximum effects on adult size compared to treatment performed during other stages
(177). Altogether, eventually we want to understand the regulatory mechanism that
control inducible and programmed metabolic transitions in flies.
First, we find that the molecular mechanisms that control the hypoxic adaptation are
more complex than the conventional ideas suggest. We show that hypoxic-induced
transcriptional adaptation response is subject to HIF-dependent and HIF-independent
regulation. dERR can interact with dHIFα, and transcriptionally modulate hypoxic
responses either together with dHIF or alone. Surprisingly, hypoxic responses
contributing glycolytic genes are not controlled by the HIF-dependent pathways, but
rather are regulated by dERR-dependent mechanisms. Also, a large portion of the
hypoxic response cannot be attribute to either dHIF or dERR action. These results
demonstrate that unknown pathways modulate hypoxic adaptation. Actually, we have
designed a genetic screen to identify those potential pathways, which could provide ideas
and perspectives for studying non-HIF hypoxic regulations in mammals. We plan to carry
out the recessive EMS screen to identify HIF-independent pathways. We will use the
well-established GAL4-UAS system, as well as the antagonizing effect of GAL80 on the
activity of GAL4 protein (178, 179). We will generate transgenic flies that express GAL4
in a HIF-dependent fashion by putting GAL4 gene under the control of HIF-dependent
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promoter (HD>GAL4), and flies that express GAL80 in a HIF-independent way by
controlling GAL80 gene by HIF-independent promoter (HI>GAL80). We will detect the
GAL4 protein using UAS-GFP strains. So, HD>GAL4 flies will express low GFP signal
in normoxia, but light up in hypoxia. Then when we combine the HD>GAL4
chromosome together with the HI>GAL80 chromosome in the same strain by crossing,
the new HD>GAL4, HD>GAL80 strain will express low GFP or no GFP signal in both
normoxia and hypoxia. Then we chemically mutate the HD>GAL4, HD>GAL80 stain
with EMS, and select those gain the ability to express GFP signal in hypoxic treatment,
which are those loss the expression of GAL80 (loss the HIF-independence pathway).
Hopefully, this strategy will provide us candidacy pathways for the puzzle of hypoxic
adaptation response.
Additionally, we also find that loss of dHIFα greatly disturbs all aspects of
carbohydrate catabolism under normoxia. This observation suggests that dHIFα might
have a role in regulation of metabolic transitions induced by larvae in development. Since
dHIFα is regulated in a post-transcriptional way, our wish to exam HIFα protein
expression in a series of developmental stages in flies has been hampered by the
availability of a good antibody. We made some effort to generate a dHIFα antibody with
little success. It is possible that we could conquer this by redesign the part of dHIFα
serving as antigen. But protein purification and design strategy for making antibody are
not our turf. We plan to collaborate with either another lab or a company to make an
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excellent antibody for us. But, overall, because dHIFα is a humongous protein with a
molecular weight of 170kD, it will be a hard western to do anyway even with a widely
used and commercially available antibody.
Previously, it is been shown that dERR is required to turn on an anabolic program
that utilizes aerobic glycolysis (Warburg metabolism) to drive rapid growth at late
embryogesis (87). Here, we demonstrate the role of dERR in turning off this aerobic
glycolysis and switching on fatty acid oxidation. We find that dERR is essential for the
transcriptional expression of CG4500, a previously uncharacterized LCFA acyl-CoA
synthetase. We found that the transcription of CG4500 is temporally induced by
starvation, and this induction is sugar sensitive. We saw that mid-L2 larvae actually
express less amount of CG4500 mRNA under starvation. But the transcription of
CG4500 is robustly induced by 24 hours starvation in one-day old male. This result is in
accordance with another study done in two wild-derived inbred strains of Drosophila.
They showed that the expression of CG4500 is induced about 3.5 times after 24 hours
starvation in the head by microarray analysis (180). However, we were not able to test
whether the starvation induction effect of CG4500 is dependent on dERR, due to the fact
that dERR mutants do not survive to adulthood. We plan to employ dERR RNAi strains
and take advantage of the heat-shock induction line, to only knock down dERR in adult
fly or other stages desired. Using this system, we could study the function of dERR in
adult flies. Because dERR greatly affects sugar metabolism in the earlier stages of larva

99

development, using the temporal knock down strategy will eliminate the cumulative
effects of dERR through development.
Furthermore, we find that the transcription of CG4500 cannot be induced by
treatment with 20% sucrose in one-day old males. This is a really interesting finding,
because it gives us a hint that sugar metabolites or the products of sugar catabolism might
be the signals activating dERR action. ERRα was the first orphan NRs ever found (4).
However, even after many years, the signaling pathways that activate ERRs remain
elusive. In mammals, co-activators, like PGC-1 or co-repressors, like RIP140, are viewed
as protein ligands for ERRs. However, only one PGC-1α-like protein has been found in
Drosophila (Spargel) but even it is not well conserved (181), and likely does not perform
similar functions based on its sequence. Furthermore, there is indeed no evidence to show
whether it interacts with or works together with dERR. We would like to study potential
binding partners for dERR. Our yeast-two hybrid study has provided several other
interesting candidates that may open avenues of investigation. So, our finding that
CG4500 induction is sugar sensitive makes us speculate that dERR is activated by
molecules involved in sugar catabolism. We plan to take advantage of available genetic
tools to knock down major steps in sugar metabolism to see which pathway can block the
sugar sensitive phenomenon. Then, we will test whether the metabolites involved in those
pathways can activate dERR activity using ERRE reporter. Hopefully, those efforts will
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lead us to new that signals stimulate ERR activities, and provide a molecular context for
understanding the ERR activation pathways in mammals.
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